SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    AACE/ACE Obesity Task Force. AACE/ACE position statement on the prevention, diagnosis, and treatment of obesity. Endocr Pract 1997; 3: 162208. (EL 4).
  • 2
    AACE/ACE Obesity Task Force. AACE/ACE position statement on the prevention, diagnosis, and treatment of obesity (1998 revision). Endocr Pract 1998; 4: 297350. (EL 4).
  • 3
    National Institutes of Health-National Heart, Lung, and Blood Institute and North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults <http:www.nhlbi.nih.govguidelinesobesityprctgd_b.pdf> (2000). Accessed 8 April 2008. (EL 4)
  • 4
    Greenway FL. Surgery for obesity. Endocrinol Metab Clin North Am 1996; 25: 10051027 (EL 4).
  • 5
    Kremen AJ, Linner JH, Nelson CH. An experimental evaluation of the nutritional importance of proximal and distal small intestine. Ann Surg 1954; 140: 439448. (EL 3).
  • 6
    Balsiger BM, Murr MM, Poggio JL, Sarr MG. Bariatric surgery: surgery for weight control in patients with morbid obesity. Med Clin North Am 2000; 84: 477489. (EL 4).
  • 7
    Griffen WO Jr., Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977; 186: 500509. (EL 3).
  • 8
    Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294: 19091917. (EL 4).
  • 9
    Alt SJ. Bariatric surgery programs growing quickly nationwide. Health Care Strateg Manage 2001; 19: 723. (EL 4).
  • 10
    DeMaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol Clin North Am 2005; 34: 127142. (EL 4).
  • 11
    Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial [with discussion]. Surg Obes Relat Dis 2007; 3: 127133 (EL 2).
  • 12
    Santry HP, Lauderdale DS, Cagney KA et al. Predictors of patient selection in bariatric surgery. Ann Surg 2007; 245: 5967. (EL 3).
  • 13
    Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006; 295: 15491555. (EL 3).
  • 14
    Greenway SE, Greenway FL III, Klein S. Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Arch Surg 2002; 137: 11091117 (EL 3).
  • 15
    Tichansky DS, DeMaria EJ, Fernandez AZ et al. Postoperative complications are not increased in super-super obese patients who undergo laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2005; 19: 939941. (EL 3).
  • 16
    World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation. Technical Report Series No. 894. World Health Organization: Geneva, Switzerland, 2000. (EL 4)
  • 17
    Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health 2007; 121: 492496. (EL 4)
  • 18
    Sturm R. Increases in clinically severe obesity in the United States, 1986–2000. Arch Intern Med 2003; 163: 21462148. (EL 4).
  • 19
    Knol JA. Management of the problem patient after bariatric surgery. Gastroenterol Clin North Am 1994; 23: 345369. (EL 4).
  • 20
    Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187193. (EL 4).
  • 21
    McTigue K, Larson JC, Valoski A. Mortality and cardiac and vascular outcomes in extremely obese women. JAMA 2006; 296: 7986. (EL 3).
  • 22
    Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr 1992; 55 (2 Suppl):615S619S. (EL 4).
  • 23
    Consensus Development Conference Panel. NIH conference: gastrointestinal surgery for severe obesity. Ann Intern Med 1991; 115: 956961. (EL 4).
  • 24
    Ontario Health Technology Advisory Committee. Bariatric Surgery: Report Summary <http:www.health.gov.on.caenglishprovidersprogrammastechreviewssum_baria_010105.html> (2005). Accessed 8 April 2008. (EL 4).
  • 25
    National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res 1998; 6 (Suppl 2):51S209S. (EL 4).
  • 26
    Newer techniques in bariatric surgery for morbid obesity. TEC Bull (Online) 2003; 20: 46. (EL 4).
  • 27
    Blue Cross Blue Shield. Special Report: The Relationship Between Weight Loss and Changes in Morbidity Following Bariatric Surgery for Morbid Obesity <http:www.diet.iecomponentoption,com_docmantask,doc_viewgid,374> (2003). Accessed 8 April 2008. (EL 4).
  • 28
    Agency for Healthcare Research and Quality. Pharmacological and Surgical Treatment of Obesity <http:www.ahrq.govclinicepcsumsobesphsum.pdf> (2004). Accessed 8 April 2008. (EL 4).
  • 29
    U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality. Screening and Interventions to Prevent Obesity in Adults. <http:www.ahrq.govclinicuspstfuspsobes.htm> (2003). Accessed 8 April 2008. (EL 4).
  • 30
    Brechner RJ, Farris C, Harrison S et al. Summary of Evidence—Bariatric Surgery <http:www.cms.hhs.govFACAdownloadsid26c.pdf> (2004). Accessed 8 April 2008. (EL 4).
  • 31
    Avenell A, Broom J, Brown TJ et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: 1182. <http:www.ncchta.orgfullmonomon821.pdf>. Accessed 25 April 2008. (EL 4).
  • 32
    Clegg AJ, Colquitt J, Sidhu MK et al. The clinical effectiveness and cost-effectiveness of surgery for people with morbid obesity: a systematic review and economic evaluation. Health Technol Assess 2002; 6: 1153. <http:www.ncchta.orgfullmonomon612.pdf>. Accessed 25 April 2008. (EL 4)
  • 33
    US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity, 2001. <http:www.surgeongeneral.govtopicsobesitycalltoactionCalltoAction.pdf> (2001). Accessed 8 April 2008. (EL 4)
  • 34
    Lehman Center Weight Loss Surgery Expert Panel. Commonwealth of Massachusetts Betsy Lehman Center for Patient Safety and Medical Error Reduction Expert Panel on Weight Loss Surgery: executive report. Obes Res 2005; 13: 20052026. (EL 4)
  • 35
    ECRI Institute. Bariatric Surgery for Obesity: Technology Assessment Report. Emergency Care Research Institute: Plymouth Meeting, PA, 2005. (EL 4)
  • 36
    Brechner RJ, Farris C, Harrison S et al. A graded, evidence-based summary of evidence for bariatric surgery. Surg Obes Relat Dis 2005; 1: 430441. (EL 4)
  • 37
    Livingston EH, Huerta S, Arthur D et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2002; 236: 576582. (EL 3)
  • 38
    Livingston EH. Procedure incidence and in-hospital complication rates of bariatric surgery in the United States. Am J Surg 2004; 188: 105110. (EL 3)
  • 39
    Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 2004; 199: 543551. (EL 3)
  • 40
    Flum DR, Salem L, Elrod JA et al. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA 2005; 294: 19031908. (EL 3)
  • 41
    Murr MM, Siadati MR, Sarr MG. Results of bariatric surgery for morbid obesity in patients older than 50 years. Obes Surg 1995; 5: 399402. (EL 2)
  • 42
    Gonzalez R, Lin E, Mattar SG, Venkatesh KR, Smith CD. Gastric bypass for morbid obesity in patients 50 years or older: is laparoscopic technique safer? Am Surg 2003; 69: 547553. (EL 3)
  • 43
    Macgregor AM, Rand CS. Gastric surgery in morbid obesity: outcome in patients aged 55 and older. Arch Surg 1993; 128: 11531157. (EL 3)
  • 44
    Sugerman HJ, DeMaria EJ, Kellum JM et al. Effects of bariatric surgery in older patients. Ann Surg 2004; 240: 243247. (EL 3)
  • 45
    Fatima J, Houghton SG, Iqbal CW et al. Bariatric surgery at the extremes of age. J Gastrointest Surg 2006; 10: 13921396. (EL 3)
  • 46
    Centers for Medicare & Medicaid Services. Medicare Expands National Coverage for Bariatric Surgery Procedures <https:www.cms.hhs.govappsmediapressrelease.aspCounter1786> (2006). Accessed 8 April 2008. (EL 4)
  • 47
    Department of Veterans Affairs and Department of Defense. VA/DoD Clinical Practice Guideline for Management of Overweight and Obesity. Version 1.0 <http:www.oqp.med.va.govcpgOBEOBE_CPGGOL.htm> (2006). Accessed 8 April 2008. (EL 4-evidence-based CPG)
  • 48
    Sarwer DB, Wadden TA, Fabricatore AN. Psychosocial and behavioral aspects of bariatric surgery. Obes Res 2005; 13: 639648. (EL 4)
  • 49
    Alvarado R, Alami RS, Hsu G et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005; 15: 12821286. (EL 3)
  • 50
    Still CD, Benotti P, Wood GC et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery. Arch Surg 2007; 142: 994998. (EL 2)
  • 51
    Alami RS, Morton JM, Schuster R et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis 2007; 3: 141145. (EL 2)
  • 52
    Jamal MK, DeMaria EJ, Johnson JM et al. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis 2006; 2: 122127. (EL 3)
  • 53
    Gibbons LM, Sarwer DB, Crerand CE et al. Previous weight loss experiences of bariatric surgery candidates: how much have patients dieted prior to surgery? Obesity 2006; 14 (Suppl 2):70S76S. (EL 3)
  • 54
    Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr 2006; 84: 304311. (EL 2)
  • 55
    Schauer PR, Ikramuddin S. Laparoscopic surgery for morbid obesity. Surg Clin North Am 2001; 81: 11451179. (EL 4)
  • 56
    Dávila-Cervantes A, Borunda D, Domínguez-Cherit G et al. Open versus laparoscopic vertical banded gastroplasty: a randomized controlled double blind trial. Obes Surg 2002; 12: 812818. (EL 2)
  • 57
    Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000; 232: 515529. (EL 3)
  • 58
    Fried M, Peskova M. Gastric banding: advantages and complications; a 5- year and 10-year follow-up. Obes Surg 1995; 5: 372374. (EL 3)
  • 59
    Fried M, Peskova M. Gastric banding in the treatment of morbid obesity. Hepatogastroenterology 1997; 44: 582587. (EL 3)
  • 60
    Gorecki P, Wise L, Brolin RE, Champion JK. Complications of combined gastric restrictive and malabsorptive procedures: part 1. Curr Surg 2003; 60: 138144. (EL 4)
  • 61
    Higa KD, Ho T, Boone KB. Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence, treatment and prevention. Obes Surg 2003; 13: 350354. (EL 3)
  • 62
    Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en Y gastric bypass: 1,040 patients—what have we learned? Obes Surg 2000; 10: 509513. (EL 2)
  • 63
    O'Brien PE, Dixon JB, Laurie C et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006; 144: 625633. (EL 2)
  • 64
    Sjöström L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 26832693. (EL 3)
  • 65
    Sjöström L, Narbro K, Sjöström CD et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741752. (EL 3)
  • 66
    Thomusch O, Keck T, Dobschütz EV et al. Risk factors for the intermediate outcome of morbid obesity after laparoscopically placed adjustable gastric banding. Am J Surg 2005; 189: 214218. (EL 2)
  • 67
    Silecchia G, Greco F, Bacci V et al. Results after laparoscopic adjustable gastric banding in patients over 55 years of age. Obes Surg 2005; 15: 351356. (EL 3)
  • 68
    O'Brien PE, Dixon JB, Laurie C, Anderson M. A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005; 15: 820826. (EL 2)
  • 69
    Talieh J, Kirgan D, Fisher BL. Gastric bypass for morbid obesity: a standard surgical technique by consensus. Obes Surg 1997; 7: 198202. (EL 3)
  • 70
    Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987; 205: 613624. (EL 2)
  • 71
    Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity [with discussion]. J Gastrointest Surg 1997; 1: 517526. (EL 3)
  • 72
    Brolin RE, LaMarca LB, Kenler HA, Cody RP. Malabsorptive gastric bypass in patients with superobesity. J Gastrointest Surg 2002; 6: 195203. (EL 3)
  • 73
    Capella JF, Capella RF. An assessment of vertical banded gastroplasty-Roux-en-Y gastric bypass for the treatment of morbid obesity. Am J Surg 2002; 183: 117123. (EL 3)
  • 74
    Fobi MA, Lee H, Felahy B et al. Choosing an operation for weight control, and the transected banded gastric bypass. Obes Surg 2005; 15: 114121. (EL 4)
  • 75
    White S, Brooks E, Jurikova L, Stubbs RS. Long-term outcomes after gastric bypass. Obes Surg 2005; 15: 155163. (EL 3)
  • 76
    Mognol P, Chosidow D, Marmuse JP. Laparoscopic conversion of laparoscopic gastric banding to Roux-en-Y gastric bypass: a review of 70 patients. Obes Surg 2004; 14: 13491353. (EL 3)
  • 77
    Gonzalez R, Gallagher SF, Haines K, Murr MM. Operative technique for converting a failed vertical banded gastroplasty to Roux-en-Y gastric bypass. J Am Coll Surg 2005; 201: 366374. (EL 3)
  • 78
    DeMaria EJ, Sugerman HJ, Kellum JM, Meader JG, Wolfe LG. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity [with discussion]. Ann Surg 2002; 235: 640647. (EL 3)
  • 79
    Scopinaro N, Gianetta E, Civalleri D, Bonalui U, Bachi V. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66: 618620. (EL 3)
  • 80
    Noya G, Cossu ML, Coppola M et al. Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases. Obes Surg 1998; 8: 6772. (EL 3)
  • 81
    Tataranni PA, Mingrone G, Raguso CA et al. Twenty-four-hour energy and nutrient balance in weight stable postobese patients after biliopancreatic diversion. Nutrition 1996; 12: 239244. (EL 3)
  • 82
    Hess DS, Hess DW. Biliopancreatic diversion with duodenal switch. Obes Surg 1998; 8: 267282. (EL 3)
  • 83
    DeMeester TR, Fuchs KH, Ball CS et al. Experimental and clinical results with proximal end-to-end duodenojejunostomy for pathologic duodenogastric reflux. Ann Surg 1987; 206: 414426. (EL 3)
  • 84
    Marceau P, Hould FS, Simard S et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22: 947954. (EL 3)
  • 85
    Gabriel SG, Karaindros CA, Papaioannou MA et al. Biliopancreatic diversion with duodenal switch combined with laparoscopic adjustable gastric banding. Obes Surg 2005; 15: 517522. (EL 3)
  • 86
    Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 2000; 10: 514523. (EL 3)
  • 87
    Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003; 13: 861864. (EL 3)
  • 88
    Almogy G, Crookes PF, Anthone GJ. Longitudinal gastrectomy as a treatment for the high-risk super-obese patient. Obes Surg 2004; 14: 492497. (EL 3)
  • 89
    Mognol P, Chosidow D, Marmuse JP. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the super-obese: a comparative study of 290 patients. Obes Surg 2005; 15: 7681. (EL 3)
  • 90
    Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy (LSG): review of a new bariatric procedure and initial results. Surg Technol Int 2006; 15: 4752. (EL 3)
  • 91
    Hamoui N, Anthone GJ, Kaufman HS, Crookes PF. Sleeve gastrectomy in the high-risk patient. Obes Surg 2006; 16: 14451449. (EL 3)
  • 92
    Cottam D, Qureshi FG, Matter SG et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006; 20: 859863. (EL 3)
  • 93
    Nguyen NT, Longoria M, Gelfand DV, Sabio A, Wilson SE. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg 2005; 15: 10771081. (EL 4)
  • 94
    Himpens J, Dapri G, Cadìere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006; 16: 14501456. (EL 2)
  • 95
    Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI ≥50). Obes Surg 2005; 15: 612617. (EL 3)
  • 96
    Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA 2005; 294: 19181924. (EL 3)
  • 97
    Pratt GM, McLees B, Pories WJ. The ASBS Bariatric Surgery Centers of Excellence program: a blueprint for quality improvement. Surg Obes Relat Dis 2006; 2: 497503. (EL 4)
  • 98
    Zhao Y, Encinosa W. Bariatric surgery utilization and outcomes in 1998 and 2004. Statistical Brief #23. Agency for Healthcare Research and Quality: Rockville, MD. <http:www.hcup-us.ahrq.govreportsstatbriefssb23.pdf> (2007). Accessed 8 April 2008. (EL 3)
  • 99
    Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis [published correction appears in JAMA 2005; 293: 1728]. JAMA 2004;292:1724–1737. (EL 1)
  • 100
    Nguyen NT, Silver M, Robinson M et al. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University HealthSystem Consortium Benchmarking Project. Arch Surg 2006; 141: 445449. (EL 3)
  • 101
    DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis 2007; 3: 134140. (EL 4)
  • 102
    Belle S. LABS Consortium. The NIDDK bariatric surgery clinical research consortium (LABS). Surg Obes Relat Dis 2005; 1: 145147. (EL 4)
  • 103
    Pories WJ, MacDonald KG Jr., Morgan EJ et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992; 55 (2 Suppl):582S585S. (EL 3)
  • 104
    Foley EF, Benotti PN, Borlase BC, Hollingshead J, Blackburn GL. Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 1992; 163: 294297. (EL 3)
  • 105
    Gleysteen JJ. Results of surgery: long-term effects on hyperlipidemia. Am J Clin Nutr 1992; 55 (2 Suppl):591S593S. (EL 3)
  • 106
    Charuzi I, Lavie P, Peiser J, Peled R. Bariatric surgery in morbidly obese sleep-apnea patients: short- and long-term follow-up. Am J Clin Nutr 1992; 55 (2 Suppl):594S596S. (EL 3)
  • 107
    Sugerman HJ, Fairman RP, Sood RK et al. Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992; 55 (2 Suppl):597S601S. (EL 3)
  • 108
    Sugerman HJ, DeMaria EJ. Gastric surgery for morbid obesity. In: Zinner MJ, Schwartz SI, Ellis H (eds). Maingot's Abdominal Operations, 10th edn. Appleton & Lange: Stamford, CT, 1997, pp 10571077. (EL 4)
  • 109
    Sugerman H, Windsor A, Bessos M, Wolfe L. Intra-abdominal pressure, sagittal abdominal diameter, and obesity comorbidity. J Intern Med 1997; 241: 7179. (EL 2)
  • 110
    Sugerman HJ, DeMaria EJ, Felton WL III, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology 1997; 49: 507511. (EL 2)
  • 111
    Sugerman H, Windsor A, Bessos M et al. Effects of surgically induced weight loss on urinary bladder pressure, sagittal abdominal diameter and obesity co-morbidity. Int J Obes Relat Metab Disord 1998; 22: 230235. (EL 2)
  • 112
    Sugerman HJ, Felton WL III, Sismanis A et al. Gastric surgery for pseudotumor cerebri associated with severe obesity [with discussion]. Ann Surg 1999; 229: 634642. (EL 3)
  • 113
    Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 2001; 81: 10631075. (VI EL 4)
  • 114
    Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005; 15: 12251232. (EL 2)
  • 115
    Cummings DE, Overduin J, Foster-Schubert KE. Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab 2004; 89: 26082615. (EL 4)
  • 116
    Cummings DE, Overduin J, Foster-Schubert KE, Carlson MJ. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 2007; 3: 109115. (EL 4)
  • 117
    Bocchieri LE, Meana M, Fisher BL. A review of psychosocial outcomes of surgery for morbid obesity. J Psychosom Res 2002; 52: 155165. (EL 4)
  • 118
    Herpertz S, Kielmann R, Wolf AM, Hebebrand J, Senf W. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004; 12: 15541569. (EL 4)
  • 119
    Herpertz S, Kielmann R, Wolf AM et al. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord 2003; 27: 13001314. (EL 4)
  • 120
    Maggard MA, Shugarman LR, Suttorp M et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547559. (EL 1)
  • 121
    Sjöström CD, Peltonen M, Sjöström L. Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 2001; 9: 188195. (EL 2)
  • 122
    Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339350. (EL 3)
  • 123
    Hickey MS, Pories WJ, MacDonald KG Jr. et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut [with discussion]? Ann Surg 1998; 227: 637644. (EL 3)
  • 124
    Cowan GS Jr., Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg 1998; 22: 987992. (EL 3)
  • 125
    Scopinaro N, Adami GF, Marinari GM et al. Biliopancreatic diversion. World J Surg 1998; 22: 936946. (EL 3)
  • 126
    Yashkov YI, Timoshin AD, Oppel TA. Vertical banded gastroplasty: first experience in Russia. Obes Surg 1997; 7: 317320. (EL 3)
  • 127
    Bourdages H, Goldenberg F, Nguyen P, Buchwald H. Improvement in obesity-associated medical conditions following vertical banded gastroplasty and gastrointestinal bypass. Obes Surg 1994; 4: 227231. (EL 3)
  • 128
    DeMaria EJ. Laparoscopic adjustable silicone gastric banding. Surg Clin North Am 2001; 81: 11291144. (VII EL 4)
  • 129
    Torquati A, Lutfi R, Abumrad N, Richards WO. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients [with discussion]? J Gastrointest Surg 2005; 9: 11121118. (EL 3)
  • 130
    Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467484. (EL 3)
  • 131
    Sanderson I, Deitel M. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Ann Surg 1974; 179: 387394. (EL 3)
  • 132
    Deitel M, Sidhu P, Stone E. Effect of vertical banded gastroplasty on diabetes in the morbidly obese [abstract]. Obes Surg 1991; 1: 113114. (EL 3)
  • 133
    Jensen K, Mason E, Scott D. Changes in the postoperative hypoglycemic and anti-hypertensive medication requirements in morbidly obese patients after VBG [abstract]. Obes Surg 1991; 1: 114. (EL 3)
  • 134
    Smith SC, Edwards CB, Goodman GN. Changes in diabetic management after Roux-en-Y gastric bypass. Obes Surg 1996; 6: 345348. (EL 3)
  • 135
    Mingrone G, DeGaetano A, Greco AV et al. Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 1997; 40: 599605. (EL 3)
  • 136
    Herbst CA, Hughes TA, Gwynne JT, Buckwalter JA. Gastric bariatric operation in insulin-treated adults. Surgery 1984; 95: 209214. (EL 3)
  • 137
    Pories WJ, MacDonald KG Jr., Flickinger EG et al. Is type II diabetes mellitus (NIDDM) a surgical disease? Ann Surg 1992; 215: 633642. (EL 3)
  • 138
    Sirinek KR, O'Dorisio TM, Hill D, McFee AS. Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass. Surgery 1986; 100: 781787. (EL 3)
  • 139
    Sugerman HJ, Wolfe LG, Sica DA, Clore JN. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 2003; 237: 751756. (EL 3)
  • 140
    Marceau P, Hould FS, Lebel S, Marceau S, Biron S. Malabsorption obesity surgery. Surg Clin North Am 2001; 81: 11131127. (EL 4)
  • 141
    Dixon JB, O'Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316323. (EL 2)
  • 142
    Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358363. (EL 2)
  • 143
    Champault A, Duwat O, Polliand C, Rizk N, Champault GG. Quality of life after laparoscopic gastric banding: prospective study (152 cases) with a follow-up of 2 years. Surg Laparosc Endosc Percutan Tech 2006; 16: 131136. (EL 2)
  • 144
    Pontiroli AE, Pizzocri P, Librenti MC et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 2002; 87: 35553561. (EL 2)
  • 145
    Pontiroli AE, Folli F, Paganelli M et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care 2005; 28: 27032709. (EL 2)
  • 146
    Long SD, O'Brien K, MacDonald KG Jr. et al. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes: a longitudinal interventional study. Diabetes Care 1994; 17: 372375. (EL 2)
  • 147
    Muscelli E, Mingrone G, Camastra S et al. Differential effect of weight loss on insulin resistance in surgically treated obese patients. Am J Med 2005; 118: 5157. (EL 3)
  • 148
    Mattar SG, Velcu LM, Rabinovitz M et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome [with discussion]. Ann Surg 2005; 242: 610620. (EL 3)
  • 149
    Tataranni PA, Mingrone G, Greco AV et al. Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion. Am J Clin Nutr 1994; 60: 320326. (EL 3)
  • 150
    Scopinaro N, Marinari GM, Camerini GB, Papadia FS, Adami GF. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up. Diabetes Care 2005; 28: 24062411. (EL 3)
  • 151
    MacDonald KG Jr., Long SD, Swanson MS et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997; 1: 213220. (EL 3)
  • 152
    Sowemimo OA, Yood SM, Courtney J et al. Natural history of morbid obesity without surgical intervention. Surg Obes Relat Dis 2007; 3: 7377. (EL 3)
  • 153
    Christou NV, Sampalis JS, Liberman M et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients [with discussion]. Ann Surg 2004; 240: 416424. (EL 3)
  • 154
    Adams TD, Gress RE, Smith SC et al. Long-term mortality following gastric bypass surgery. N Engl J Med 2007; 357: 753761. (EL 2)
  • 155
    Busetto L, Miribelli D, Petroni ML et al. Comparative long-term mortality after laparoscopic adjustable gastric banding versus nonsurgical controls. Surg Obes Relat Dis 2007; 3: 496502. (EL 3)
  • 156
    Sugerman HJ, Londrey GL, Kellum JM et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg 1989; 157: 93102. (EL 2)
  • 157
    Hudson SM, Dixon JB, O'Brien PE. Sweet eating is not a predictor of outcome after Lap-Band placement: can we finally bury the myth? Obes Surg 2002; 12: 789794. (EL 3)
  • 158
    Lindroos AK, Lissner L, Sjöström L. Weight change in relation to intake of sugar and sweet foods before and after weight reducing gastric surgery. Int J Obes Relat Metab Disord 1996; 20: 634643. (EL 3)
  • 159
    American Association of Clinical Endocrinologists Ad Hoc Task Force for Standardized Production of Clinical Practice Guidelines. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines. Endocr Pract. 2004; 10: 353361. (EL 4)
  • 160
    Johnson N. New approaches to the development of treatment guidelines. Formulary. 1998; 33: 665678. (EL 4)
  • 161
    Cohen RV, Schiavon CA, Pinheiro JS, Correa JL, Rubino F. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis 2007; 3: 195197. (EL 3)
  • 162
    Rubino F, Gagner M, Gentileschi P et al. The early effect of the Roux-en-Y gastric bypass on hormones is involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236242. (EL 3)
  • 163
    Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474481. (EL 3)
  • 164
    MacDonald PE, El-Kholy M, Riedel MJ et al. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion. Diabetes 2002; 51 (Suppl 3):S434S442. (EL 4)
  • 165
    de Paula AL, Macedo AL, Prudente AS et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis 2006; 2: 464467. (EL 3)
  • 166
    Infanger D, Baldinger R, Branson R et al. Effect of significant intermediate-term weight loss on serum leptin levels and body composition in severely obese subjects. Obes Surg 2003; 13: 879888. (EL 2)
  • 167
    Holdstock C, Engström BE, Ohrvall M et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab 2003; 88: 31773183. (EL 3)
  • 168
    Guldstrand M, Ahrén B, Adamson U. Improved beta-cell function after standardized weight reduction in severely obese subjects. Am J Physiol Endocrinol Metab 2003; 284: E557E565. (EL 3)
  • 169
    Faraj M, Havel PJ, Phélis S et al. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 2003; 88: 15941602. (EL 3)
  • 170
    Vendrell J, Broch M, Vilarrasa N et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962971. (EL 2)
  • 171
    Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 2002; 236: 554559. (EL 4)
  • 172
    Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 111. (EL 4)
  • 173
    Rubino F, Zizzari P, Tomasetto C et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 2005; 146: 17451751. (EL 4)
  • 174
    Dixon JB, Schachter LM, O'Brien PE. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes 2005; 29: 10481054. (EL 3)
  • 175
    Peiser J, Ovnat A, Uwyyed K, Lavie P, Charuzi I. Cardiac arrhythmias during sleep in morbidly obese sleep-apneic patients before and after gastric bypass surgery. Clin Cardiol 1985; 8: 519521. (EL 3)
  • 176
    Sugerman HJ, Fairman RP, Baron PL, Kwentus JA. Gastric surgery for respiratory insufficiency of obesity. Chest 1986; 90: 8186. (EL 3)
  • 177
    Sugerman HJ, Baron PL, Fairman RP, Evans CR, Vetrovec GW. Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss [with discussion]. Ann Surg 1988; 207: 604613. (EL 3)
  • 178
    Charuzi I, Fraser D, Peiser J, Ovnat A, Lavie P. Sleep apnea syndrome in the morbidly obese undergoing bariatric surgery. Gastroenterol Clin North Am 1987; 16: 517519. (EL 4)
  • 179
    Rasheid S, Banasiak M, Gallagher SF et al. Gastric bypass is an effective treatment for obstructive sleep apnea in patients with clinically significant obesity. Obes Surg 2003; 13: 5861. (EL 2)
  • 180
    Kalra M, Inge T. Effect of bariatric surgery on obstructive sleep apnoea in adolescents. Paediatr Respir Rev 2006; 7: 260267. (EL 4)
  • 181
    Fritscher LG, Mottin CC, Canani S, Chatkin JM. Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg 2007; 17: 9599. (EL 4)
  • 182
    Dixon JB, Chapman L, O'Brien P. Marked improvement in asthma after Lap-Band surgery for morbid obesity. Obes Surg 1999; 9: 385389. (EL 3)
  • 183
    Dixon JB, O'Brien PE. Lipid profile in the severely obese: changes with weight loss after Lap-Band surgery. Obes Res 2002; 10: 903910. (EL 3)
  • 184
    Gleysteen JJ, Barboriak JJ. Improvement in heart disease risk factors after gastric bypass. Arch Surg 1983; 118: 681684. (EL 3)
  • 185
    Buffington CK, Cowan GS Jr., Smith H. Significant changes in the lipid-lipoprotein status of premenopausal morbidly obese females following gastric bypass surgery. Obes Surg 1994; 4: 328335. (EL 3)
  • 186
    Wolf AM, Beisiegel U, Kortner B, Kuhlmann HW. Does gastric restriction surgery reduce the risks of metabolic diseases? Obes Surg 1998; 8: 913. (EL 3)
  • 187
    Busetto L, Pisent C, Rinaldi D et al. Variation in lipid levels in morbidly obese patients operated with the Lap-Band adjustable gastric banding system: effects of different levels of weight loss. Obes Surg 2000; 10: 569577. (EL 2)
  • 188
    Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastroenterol Surg 2000; 4: 464469. (EL 2)
  • 189
    Sjöström CD, Lissner L, Wedel H, Sjöström L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477484. (EL 1)
  • 190
    Lubrano C, Cornoldi A, Pili M et al. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years’ follow-up. Int J Obes Relat Metab Disord 2004; 28: 16001606. (EL 3)
  • 191
    Palomar R, Fernández-Fresnedo G, Dominguez-Diez A et al. Effects of weight loss after biliopancreatic diversion on metabolism and cardiovascular profile. Obes Surg 2005; 15: 794798. (EL 3)
  • 192
    Corradini SG, Eramo A, Lubrano C et al. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 2005; 15: 367377. (EL 3)
  • 193
    Zlabek JA, Grimm MS, Larson CJ et al. The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 2005; 1: 537542. (EL 2)
  • 194
    Vogel JA, Franklin BA, Zalesin KC et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol 2007; 99: 222226. (EL 3)
  • 195
    Williams DB, Hagedorn JC, Lawson EH et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis 2007; 3: 813. (EL 2)
  • 196
    Dixon JB, O'Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2). Int J Obes Relat Metab Disord 2001; 25: 793797. (EL 2)
  • 197
    Carson JL, Ruddy ME, Duff AE et al. The effect of gastric bypass surgery on hypertension in morbidly obese patients [published correction appears in Arch Intern Med 1994; 154: 1770]. Arch Intern Med 1994;154:193–200. (EL 3)
  • 198
    Ben-Dov I, Grossman E, Stein A, Shachor D, Gaides M. Marked weight reduction lowers resting and exercise blood pressure in morbidly obese subjects. Am J Hypertens 2000; 13: 251255. (EL 3)
  • 199
    Fernstrom JD, Courcoulas AP, Houck PR, Fernstrom MH. Long-term changes in blood pressure in extremely obese patients who have undergone bariatric surgery. Arch Surg 2006; 141: 276283. (EL 3)
  • 200
    Sjöström CD, Peltonen M, Wedel H, Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 2025. (EL 2)
  • 201
    Messerli FH, Sundgaard-Riise K, Reisin ED et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med 1983; 99: 757761. (EL 3)
  • 202
    Alpert MA, Lambert CR, Terry BE et al. Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 1995; 130: 10681073. (EL 2)
  • 203
    Karason K, Wallentin I, Larsson B, Sjöström L. Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study. BMJ 1997; 315: 912916. (EL 3)
  • 204
    Karason K, Wallentin I, Larsson B, Sjöström L. Effects of obesity and weight loss on cardiac function and valvular performance. Obes Res 1998; 6: 422429. (EL 2)
  • 205
    Kanoupakis E, Michaloudis D, Fraidakis O et al. Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg 2001; 11: 552558. (EL 3)
  • 206
    Cunha Lde C, da Cunha CL, de Souza AM et al. Evolutive echocardiographic study of the structural and functional heart alterations in obese individuals after bariatric surgery [article in Portuguese]. Arq Bras Cardiol 2006; 87: 615622. (EL 3)
  • 207
    Leichman JG, Aguilar D, King TM et al. Improvements in systemic metabolism, anthropometrics, and left ventricular geometry 3 months after bariatric surgery. Surg Obes Relat Dis 2006; 2: 592599. (EL 3)
  • 208
    Iyengar S, Leier CV. Rescue bariatric surgery for obesity-induced cardiomyopathy. Am J Med 2006; 119: e5e6. (EL 3)
  • 209
    Manson JE, Colditz GA, Stampfer MJ et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882889. (EL 2)
  • 210
    Manson JE, Willett WC, Stampfer MJ et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677685. (EL 2)
  • 211
    Sampalis JS, Sampalis F, Christou N. Impact of bariatric surgery on cardiovascular and musculoskeletal morbidity. Surg Obes Relat Dis 2006; 2: 587591. (EL 2)
  • 212
    Smith SC, Edwards CB, Goodman GN. Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass. Obes Surg 1997; 7: 479484. (EL 3)
  • 213
    Frezza EE, Ikramuddin S, Gourash W et al. Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 2002; 16: 10271031. (EL 3)
  • 214
    Nelson LG, Gonzalez R, Haines K, Gallagher SF, Murr MM. Amelioration of gastroesophageal reflux symptoms following Roux-en-Y gastric bypass for clinically significant obesity [with discussion]. Am Surg 2005; 71: 950954. (EL 3)
  • 215
    Lenglinger J, Eisler M, Riegler M. Obesity and GERD: implications and consequences for bariatric surgery? Am J Gastroenterol 2005; 100: 26002601. (EL 4)
    Direct Link:
  • 216
    Cobey F, Oelschlager B. Complete regression of Barrett's esophagus after Roux-en-Y gastric bypass. Obes Surg 2005; 15: 710712. (EL 3)
  • 217
    Deitel M, Khanna RK, Hagen J, Ilves R. Vertical banded gastroplasty as an antireflux procedure. Am J Surg 1988; 155: 512516. (EL 3)
  • 218
    Gholam PM, Kotler DP, Flancbaum LJ. Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg 2002; 12: 4951. (EL 3)
  • 219
    Shaffer EA. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol 2006; 40 (3 Suppl 1):S44S50. (EL 4)
  • 220
    Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315322. (EL 4)
  • 221
    Dixon JB. Surgical treatment for obesity and its impact on non-alcoholic steatohepatitis. Clin Liver Dis 2007; 11: 141154, ix-x. (EL 4)
  • 222
    Dixon JB, Bhathal PS, Hughes NR, O'Brien PE. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 16471654. (EL 2)
  • 223
    Ranlov I, Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990; 47: 208214. (EL 3)
  • 224
    Silverman EM, Sapala JA, Appelman HD. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 1995; 104: 2331. (EL 2)
  • 225
    Luyckx FH, Desaive C, Thiry A et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 1998; 22: 222226. (EL 3)
  • 226
    Duchini A, Brunson ME. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation 2001; 72: 156159. (EL 3)
  • 227
    Clark JM, Alkhuraishi AR, Solga SF et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 2005; 13: 11801186. (EL 3)
  • 228
    Barker KB, Palekar NA, Bowers SP et al. Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. Am J Gastroenterol 2006; 101: 368373. (EL 3)
    Direct Link:
  • 229
    Jaskiewicz K, Raczynska S, Rzepko R, Sledzinski Z. Nonalcoholic fatty liver disease treated by gastroplasty. Dig Dis Sci 2006; 51: 2126. (EL 3)
  • 230
    Mathurin P, Gonzalez F, Kerdraon O et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 2006; 130: 16171624. (EL 2)
  • 231
    Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005; 352: 12231236. (EL 4)
  • 232
    Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 40754079. (EL 2)
  • 233
    Legro RS, Barnhart HX, Schlaff WD et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007; 356: 551566. (EL 1)
  • 234
    Dixon JB, O'Brien PE. Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Clin Endocrinol (Oxf) 2002; 57: 769778. (EL 2)
  • 235
    Deitel M, To TB, Stone E, Sutherland DJ, Wilk EJ. Sex hormonal changes accompanying loss of massive excess weight. Gastroenterol Clin North Am 1987; 16: 511515. (EL 4)
  • 236
    Escobar-Morreale HF, Botella-Carretero JI, Alvarez-Blasco F, Sancho J, Millán San JL. The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2005; 90: 63646369. (EL 3)
  • 237
    Eid GM, Cottam DR, Velcu LM et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis 2005; 1: 7780. (EL 3)
  • 238
    Teitelman M, Grotegut CA, Williams NN, Lewis JD. The impact of bariatric surgery on menstrual patterns. Obes Surg 2006; 16: 14571463. (EL 3)
  • 239
    Kopp HP, Kryzanowska K, Schernthaner GH, Kriwanek S, Schernthaner G. Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplasty. Obes Surg 2006; 16: 12141220. (EL 2)
  • 240
    Alagna S, Cossu ML, Gallo P et al. Biliopancreatic diversion: long-term effects on gonadal function in severely obese men. Surg Obes Relat Dis 2006; 2: 8286. (EL 3)
  • 241
    Strain GW, Zumoff B. The effect of bariatric surgery on the abnormalities of the pituitary-gonadal axis in obese men. Surg Obes Relat Dis 2006; 2: 7577. (EL 4)
  • 242
    Dixon JB, Dixon ME, O'Brien PE. Pregnancy after Lap-Band surgery: management of the band to achieve healthy weight outcomes. Obes Surg 2001; 11: 5965. (EL 3)
  • 243
    Dixon JB, Dixon ME, O'Brien PE. Birth outcomes in obese women after laparoscopic adjustable gastric banding. Obstet Gynecol 2005; 106: 965972. (EL 2)
  • 244
    Friedman D, Cunco S, Valenzano M et al. Pregnancies in an 18-year follow-up after biliopancreatic diversion. Obes Surg 1995; 5: 308313. (EL 3)
  • 245
    Wittgrove AC, Jester L, Wittgrove P, Clark GW. Pregnancy following gastric bypass for morbid obesity. Obes Surg 1998; 8: 461464. (EL 3)
  • 246
    Skull AJ, Slater GH, Duncombe JE, Fielding GA. Laparoscopic adjustable banding in pregnancy: safety, patient tolerance and effect on obesity-related pregnancy outcomes. Obes Surg 2004; 14: 230235. (EL 3)
  • 247
    Sheiner E, Levy A, Silverberg D et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol 2004; 190: 13351340. (EL 3)
  • 248
    Dao T, Kuhn J, Ehmer D, Fisher T, McCarty T. Pregnancy outcomes after gastric-bypass surgery. Am J Surg 2006; 192: 762766. (EL 3)
  • 249
    Kral JG, Biron S, Simard S et al. Large maternal weight loss from obesity surgery prevents transmission of obesity to children who were followed from 2 to 18 years. Pediatrics 2006; 118: 16441649. (EL 3)
  • 250
    Sugerman HJ, Sugerman EL, Wolfe L et al. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg 2001; 234: 4146. (EL 3)
  • 251
    Bloomfield GL, Ridings PC, Blocher CR, Marmarou A, Sugerman HJ. Effects of increased intra-abdominal pressure upon intracranial and cerebral perfusion pressure before and after volume expansion [with discussion]. J Trauma 1996; 40: 936943. (EL 4)
  • 252
    Bloomfield GL, Ridings PC, Blocher CR, Marmarou A, Sugerman HJ. A proposed relationship between increased intra-abdominal, intrathoracic, and intracranial pressure. Crit Care Med 1997; 25: 496503. (EL 4)
  • 253
    Rosenberg ML, Corbett JJ, Smith C et al. Cerebrospinal fluid diversion procedures in pseudotumor cerebri. Neurology 1993; 43: 10711072. (EL 3)
  • 254
    Nadkarni T, Rekate HL, Wallace D. Resolution of pseudotumor cerebri after bariatric surgery for related obesity: case report. J Neurosurg 2004; 101: 878880. (EL 4)
  • 255
    Chandra V, Dutta S, Albanese CT et al. Clinical resolution of severely symptomatic pseudotumor cerebri after gastric bypass in an adolescent. Surg Obes Relat Dis 2007; 3: 198200. (EL 3)
  • 256
    Bump RC, Sugerman HJ, Fantl JA, McClish DK. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol 1992; 167: 392397. (EL 3)
  • 257
    Richter HE, Burgio KL, Clements RH et al. Urinary and anal incontinence in morbidly obese women considering weight loss surgery. Obstet Gynecol 2005; 106: 12721277. (EL 3)
  • 258
    Deitel M, Stone E, Kassam HA, Wilk EJ, Sutherland DJ. Gynecologic-obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 1988; 7: 147153. (EL 3)
  • 259
    Nevitt MC. Obesity outcomes in disease management: clinical outcomes for osteoarthritis. Obes Res 2002; 10 (Suppl 1):33S37S. (EL 4)
  • 260
    Winiarsky R, Barth P, Lotke P. Total knee arthroplasty in morbidly obese patients. J Bone Joint Surg Am 1998; 80: 17701774. (EL 3)
  • 261
    McKee MD, Waddell JP. Intramedullary nailing of femoral fractures in morbidly obese patients. J Trauma 1994; 36: 208210. (EL 3)
  • 262
    Böstman OM. Body mass index and height in patients requiring surgery for lumbar intervertebral disc herniation. Spine 1993; 18: 851854. (EL 3)
  • 263
    Parvizi J, Trousdale RT, Sarr MG. Total joint arthroplasty in patients surgically treated for morbid obesity. J Arthroplasty 2000; 15: 10031008. (EL 3)
  • 264
    Peltonen M, Lindroos AK, Torgerson JS. Musculoskeletal pain in the obese: a comparison with a general population and long-term changes after conventional and surgical obesity treatment. Pain 2003; 104: 549557. (EL 3)
  • 265
    Abu-Abeid S, Wishnitzer N, Szold A, Liebergall M, Manor O. The influence of surgically-induced weight loss on the knee joint [published correction appears in Obes Surg 2006; 16: 530]. Obes Surg 2005;15:1437–1442. (EL 2)
  • 266
    Hooper MM, Stellato TA, Hallowell PT, Seitz BA, Moskowitz RW. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 2007; 31: 114120. (EL 3)
  • 267
    Melissas J, Volakakis E, Hadjipavlou A. Low-back pain in morbidly obese patients and the effect of weight loss following surgery. Obes Surg 2003; 13: 389393. (EL 3)
  • 268
    Serés L, Lopez-Ayerbe J, Coll R et al. Increased exercise capacity after surgically induced weight loss in morbid obesity. Obes Res 2006; 14: 273279. (EL 2)
  • 269
    Maniscalco M, Zedda A, Giardiello C et al. Effect of bariatric surgery on the six-minute walk test in severe uncomplicated obesity. Obes Surg 2006; 16: 836841. (EL 3)
  • 270
    Teasdale N, Hue O, Marcotte J et al. Reducing weight increases postural stability in obese and morbid obese men. Int J Obes (Lond) 2007; 31: 153160. (EL 3)
  • 271
    Larsen F. Psychosocial function before and after gastric banding surgery for morbid obesity: a prospective psychiatric study. Acta Psychiatr Scand Suppl 1990; 359: 157. (EL 3)
  • 272
    Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry 1992; 149: 227234. (EL 3)
  • 273
    Powers PS, Rosemurgy A, Boyd F, Perez A. Outcome of gastric restriction procedures: weight, psychiatric diagnoses, and satisfaction. Obes Surg 1997; 7: 471477. (EL 3)
  • 274
    Sarwer DB, Cohn NI, Gibbons LM et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg 2004; 14: 11481156. (EL 3)
  • 275
    Adami GF, Gandolfo P, Bauer B, Scopinaro N. Binge eating in massively obese patients undergoing bariatric surgery. Int J Eat Disord 1995; 17: 4550. (EL 3)
  • 276
    Hsu LK, Sullivan SP, Benotti PN. Eating disturbances and outcome of gastric bypass surgery: a pilot study. Int J Eat Disord 1997; 21: 385390. (EL 3)
  • 277
    Hsu LK, Benotti PN, Dwyer J et al. Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med 1998; 60: 338346. (EL 4)
  • 278
    Hsu LK, Mulliken B, McDonagh B et al. Binge eating disorder in extreme obesity. Int J Obes Relat Metab Disord 2002; 26: 13981403. (EL 3)
  • 279
    Huang CS, Farraye FA. Endoscopy in the bariatric surgical patient. Gastroenterol Clin North Am 2005; 34: 151166. (EL 4)
  • 280
    Kalarchian MA, Wilson GT, Brolin RE, Bradley L. Binge eating in bariatric surgery patients. Int J Eat Disord 1998; 23: 8992. (EL 3)
  • 281
    Kalarchian MA, Wilson GT, Brolin RE, Bradley L. Assessment of eating disorders in bariatric surgery candidates: self-report questionnaire versus interview. Int J Eat Disord 2000; 28: 465469. (EL 3)
  • 282
    Kalarchian MA, Marcus MD, Wilson GT et al. Binge eating among gastric bypass patients at long-term follow-up. Obes Surg 2002; 12: 270275. (EL 3)
  • 283
    Powers PS, Perez A, Boyd F, Rosemurgy A. Eating pathology before and after bariatric surgery: a prospective study. Int J Eat Disord 1999; 25: 293300. (EL 3)
  • 284
    Allison KC, Wadden TA, Sarwer DB et al. Night eating syndrome and binge eating disorder among persons seeking bariatric surgery: prevalence and related features. Obesity (Silver Spring) 2006; 14 (Suppl 2):77S82S. (EL 3)
  • 285
    de Zwaan M, Mitchell JE, Howell LM et al. Characteristics of morbidly obese patients before gastric bypass surgery. Compr Psychiatry 2003; 44: 428434. (EL 3)
  • 286
    Fabricatore AN, Wadden TA, Sarwer DB, Faith MS. Health-related quality of life and symptoms of depression in extremely obese persons seeking bariatric surgery. Obes Surg 2005; 15: 304309. (EL 3)
  • 287
    Wadden TA, Sarwer DB, Womble LG et al. Psychosocial aspects of obesity and obesity surgery. Surg Clin North Am 2001; 81: 10011024. (EL 4)
  • 288
    Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev 2001; 2: 173182. (EL 4)
  • 289
    Sarwer DB, Thompson JK, Cash TF. Body image and obesity in adulthood. Psychiatr Clin North Am 2005; 28: 6987. (EL 4)
  • 290
    Puhl R, Brownell KD. Bias, discrimination, and obesity. Obes Res 2001; 9: 788805. (EL 4)
  • 291
    Klesges RC, Klem ML, Hanson CL et al. The effects of applicant's health status and qualifications on simulating hiring decisions. Int J Obes 1990; 14: 527535. (EL 3)
  • 292
    Pingitore R, Dugoni BL, Tindale RS, Spring B. Bias against overweight job applicants in a simulated employment interview. J Appl Psychol 1994; 79: 909917. (EL 3)
  • 293
    van Hout GC, Boekestein P, Fortuin FA, Pelle AJ, van Heck GL. Psychosocial functioning following bariatric surgery. Obes Surg 2006; 16: 787794. (EL 4)
  • 294
    Nguyen NT, Goldman C, Rosenquist CJ et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs [with discussion]. Am Surg 2001; 234: 279291. (EL 2)
  • 295
    Rand CS, Macgregor A, Hankins G. Gastric bypass surgery for obesity: weight loss, psychosocial outcome, and morbidity one and three years later. South Med J 1986; 79: 15111514. (EL 3)
  • 296
    Dixon JB, Dixon ME, O'Brien PE. Body image: appearance orientation and evaluation in the severely obese; changes with weight loss. Obes Surg 2002; 12: 6571. (EL 3)
  • 297
    Dziurowicz-Kozlowska A, Lisik W, Wierzbicki Z, Kosieradzki M. Health-related quality of life after surgical treatment of obesity. J Physiol Pharmacol 2005; 56 (Suppl 6):127134. (EL 3)
  • 298
    Mamplekou E, Komesidou V, Bissias Ch, Papakonstantinou A, Melissas J. Psychological condition and quality of life in patients with morbid obesity before and after surgical weight loss. Obes Surg 2005; 15: 11771184. (EL 3)
  • 299
    Velcu LM, Adolphine R, Mourelo R, Cottam DR, Angus LD. Weight loss, quality of life and employment status after Roux-en-Y gastric bypass: a 5-year analysis. Surg Obes Relat Dis 2006; 1: 413416. (EL 3)
  • 300
    Sanchez-Santos R, Del Barrio MJ, Gonzalez C et al. Long-term health-related quality of life following gastric bypass: influence of depression. Obes Surg 2006; 16: 580585. (EL 3)
  • 301
    Mitchell JE, Lancaster KL, Burgard MA et al. Long-term follow-up of patients’ status after gastric bypass. Obes Surg 2001; 11: 464468. (EL 3)
  • 302
    Rand CS, Kuldau JM, Robbins L. Surgery for obesity and marriage quality. JAMA 1982; 247: 14191422. (EL 3)
  • 303
    Peeters A, O'Brien PE, Laurie C et al. Substantial intentional weight loss and mortality in the severely obese. Ann Surg 2007; 246: 10281033. (EL 3)
  • 304
    Kushner RF, Roth JL. Assessment of the obese patient. Endocrinol Metab Clin North Am 2003; 32: 915933. (EL 4)
  • 305
    Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N. Psychiatric medication-induced obesity: a review. Obes Rev 2004; 5: 115121. (EL 4)
  • 306
    Schwartz TL, Nihalani N, Virk S, Jindal S, Chilton M. Psychiatric medication-induced obesity: treatment options. Obes Rev 2004; 5: 233238. (EL 4)
  • 307
    Wadden TA, Foster GD. Weight and lifestyle inventory (WALI). Obesity (Silver Spring) 2006; 14 (Suppl 2):99S118S. (EL 4)
  • 308
    Sarwer DB, Fabricatore AN, Wadden TA. The behavioral evaluation of bariatric surgery candidates. Obes Manag 2006; 2: 103109. (EL 4)
  • 309
    Wadden TA, Sarwer DB. Behavioral assessment of candidates for bariatric surgery: a patient-oriented approach. Obesity (Silver Spring) 2006; 14 (Suppl 2):53S62S. (EL 4)
  • 310
    Foster GD, Wadden TA, Phelan S, Sarwer DB, Sanderson RS. Obese patients’ perceptions of treatment outcomes and the factors that influence them. Arch Intern Med 2001; 161: 21332139. (EL 3)
  • 311
    Sogg S, Mori DL. The Boston interview for gastric bypass: determining the psychological suitability of surgical candidates. Obes Surg 2004; 14: 370380. (EL 4)
  • 312
    Fabricatore AN, Crerand CE, Wadden TA, Sarwer DB, Krasucki JL. How do mental health professionals evaluate candidates for bariatric surgery? Survey results. Obes Surg 2006; 16: 567573. (EL 3)
  • 313
    Bauchowitz AU, Gonder-Frederick LA, Olbrisch ME et al. Psychosocial evaluation of bariatric surgery candidates: a survey of present practices. Psychosom Med 2005; 67: 825832. (EL 3)
  • 314
    Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life—a Swedish population study. Int J Obes Relat Metab Disord 2002; 26: 417424. (EL 3)
  • 315
    Sullivan M, Karlsson J, Sjöström L et al. Swedish Obese Subjects (SOS)—an intervention study of obesity: baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined. Int J Obes Relat Metab Disord 1993; 17: 503512. (EL 3)
  • 316
    Camps MA, Zervos E, Goode S, Rosemurgy AS. Impact of bariatric surgery on body image perception and sexuality in morbidly obese patients and their partners. Obes Surg 1996; 6: 356360. (EL 3)
  • 317
    Karlsson J, Sjöström L, Sullivan M. Swedish Obese Subjects (SOS)—an intervention study of obesity: two-year follow-up of health-related quality of life (HRQL) and eating behavior after gastric surgery for severe obesity. Int J Obes Relat Metab Disord 1998; 22: 113126. (EL 1)
  • 318
    Pawlow LA, O'Neil PM, White MA, Byme TK. Findings and outcomes of psychological evaluations of gastric bypass applicants [with discussion]. Surg Obes Relat Dis 2005; 1: 523529. (EL 3)
  • 319
    Surrat PM, Findley LJ. Clinical Manifestations and Diagnosis of Obesity Hypoventilation Syndrome <http:www.uptodate.comonline> (2003). Accessed 22 April 2008. (EL 4)
  • 320
    Raff H, Findling JW. A physiologic approach to diagnosis of the Cushing syndrome. Ann Intern Med 2003; 138: 980991. (EL 4)
  • 321
    Dunaif A, Lobo RA. Toward optimal health: the experts discuss polycystic ovary syndrome. J Womens Health Gend Based Med 2002; 11: 579584. (EL 4)
  • 322
    American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 17021704. (EL 4)
  • 323
    Clark JM, Diehl AM. Nonalcoholic fatty liver disease an underrecognized cause of cryptogenic cirrhosis. JAMA 2003; 289: 30003004. (EL 3)
  • 324
    Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet 2003; 361: 20322035. (EL 3)
  • 325
    American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Practice advisory for preanesthesia evaluation: a report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2002; 96: 485496. (EL 4)
  • 326
    Flancbaum L, Belsley S, Drake V, Colarusso T, Tayler E. Preoperative nutritional status of patients undergoing Roux-en-Y gastric bypass for morbid obesity. J Gastrointest Surg 2006; 10: 10331037. (EL 3)
  • 327
    Madan AK, Orth WS, Tichansky DS, Ternovits CA. Vitamin and trace mineral levels after laparoscopic gastric bypass. Obes Surg 2006; 16: 603606. (EL 3)
  • 328
    Zeni TM, Frantzides CT, Mahr C et al. Value of preoperative upper endoscopy in patients undergoing laparoscopic gastric bypass. Obes Surg 2006; 16: 142146. (EL 3)
  • 329
    Vanek VW, Catania M, Triveri K, Woodruff RW Jr. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 1722. (EL 3)
  • 330
    Brolin RE. Gastric bypass. Surg Clin North Am 2001; 81: 10771095. (EL 4)
  • 331
    Sauerland S, Angrisani L, Belachew M et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005; 19: 200221. (EL 4)
  • 332
    O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg 2006; 16: 10321040. (EL 1)
  • 333
    Chapman AE, Kiroff G, Game P et al. Laparoscopic adjustable gastric banding in the treatment of obesity—a systematic literature review. Surgery 2004; 135: 326351. (EL 4)
  • 334
    O'Brien PE, Brown WA, Smith A, McMurrick PJ, Stephens M. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity. Br J Surg 1999; 86: 113118. (EL 2)
  • 335
    Scopinaro N, Gianetta E, Adami GF et al. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119: 261268. (EL 3)
  • 336
    Puzziferri N, Austrheim-Smith IT, Wolfe BM, Wilson SE, Nguyen NT. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 2006; 243: 181188. (EL 2)
  • 337
    Buchwald H. A bariatric surgery algorithm. Obes Surg 2002; 12: 733746. (EL 4)
  • 338
    Dolan K, Hatzifotis M, Newbury L, Fielding G. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004; 14: 165169. (EL 2)
  • 339
    Fielding GA. Laparoscopic adjustable gastric banding for massive superobesity (>60 body mass index kg/m2). Surg Endosc 2003; 17: 15411545. (EL 3)
  • 340
    Parikh MS, Shen R, Weiner M, Siegel N, Ren CJ. Laparoscopic bariatric surgery in super-obese patients (BMI >50) is safe and effective: a review of 332 patients. Obes Surg 2005; 15: 858863. (EL 3)
  • 341
    Hall JC, Watts JM, O'Brien PE et al. Gastric surgery for morbid obesity: the Adelaide Study. Ann Surg 1990; 211: 419427. (EL 3)
  • 342
    Howard L, Malone M, Michalek A et al. Gastric bypass and vertical banded gastroplasty: a prospective randomized comparison and 5-year follow-up. Obes Surg 1995; 5: 5560. (EL 2)
  • 343
    MacLean LD, Rhode BM, Forse RA, Nohr R. Surgery for obesity—an update of a randomized trial. Obes Surg 1995; 5: 145150. (EL 2)
  • 344
    Weber M, Muller MK, Bucher T et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 2004; 240: 975982. (EL 2)
  • 345
    Jan JC, Hong D, Pereira N, Patterson EJ. Laparoscopic adjustable gastric banding versus laparoscopic gastric bypass for morbid obesity: a single-institution comparison study of early results [with discussion]. J Gastrointest Surg 2005; 9: 3041. (EL 2)
  • 346
    Jan JC, Hong D, Bardaro SJ, July LV, Patterson EJ. Comparative study between laparoscopic adjustable gastric banding and laparoscopic gastric bypass: single-institution, 5-year experience in bariatric surgery [published correction appears in Surg Obes Relat Dis 2007; 3: 203]. Surg Obes Relat Dis 2007;3:42–50. (EL 2)
  • 347
    Baltasar A, Bou R, Bengochea M et al. Duodenal switch: an effective therapy for morbid obesity—intermediate results. Obes Surg 2001; 11: 5458. (EL 3)
  • 348
    Baltasar A, del Rio J, Escrivá C et al. Preliminary results of the duodenal switch. Obes Surg 1997; 7: 500504. (EL 3)
  • 349
    Michielson D, Van Hee R, Hendrickx L. Complications of biliopancreatic diversion surgery as proposed by Scopinaro in the treatment of morbid obesity. Obes Surg 1996; 6: 416420. (EL 3)
  • 350
    Antal SC. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg 1994; 4: 285290. (EL 3)
  • 351
    Torres JC. Prevention and reversal of liver damage following bypass diversion for obesity. Obes Surg 1995; 5: 81. (EL 3)
  • 352
    Kral JG, Thung SN, Biron S et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004; 135: 4858. (EL 2)
  • 353
    Martinez Castro R, Baltasar A, Vidal V, Sánchez Cuenca J, Liedó JL. Gastric emptying in patients with morbid obesity treated with a duodenal switch [article in Spanish]. Rev Esp Enferm Dig 1997; 89: 413414. (EL 3)
  • 354
    Marceau P, Biron S, Bourque RA et al. Biliopancreatic diversion with a new type of gastrectomy. Obes Surg 1993; 3: 2935. (EL 4)
  • 355
    Rabkin RA, Rabkin JM, Metcalf B et al. Laparoscopic technique for performing duodenal switch with gastric reduction. Obes Surg 2003; 13: 263268. (EL 3)
  • 356
    Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese: a prospective randomized study. Ann Surg 1992; 215: 387395. (EL 2)
  • 357
    Sugerman HJ. Bariatric surgery for severe obesity. J Assoc Acad Minor Phys 2001; 12: 129136. (EL 4)
  • 358
    Azagra JS, Goergen M, Ansay J et al. Laparoscopic gastric reduction surgery: preliminary results of a randomized, prospective trial of laparoscopic vs open vertical banded gastroplasty. Surg Endosc 1999; 13: 555558. (EL 2)
  • 359
    de Wit LT, Mathus-Vliegen L, Hey C et al. Open versus laparoscopic adjustable silicone gastric banding: a prospective randomized trial for treatment of morbid obesity [with discussion]. Ann Surg 1999; 230: 800807. (EL 2)
  • 360
    Luján JA, Frutos MD, Hernández Q et al. Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 2004; 239: 433437. (EL 2)
  • 361
    Sundbom M, Gustavsson S. Randomized clinical trial of hand-assisted laparoscopic versus open Roux-en-Y gastric bypass for the treatment of morbid obesity. Br J Surg 2004; 91: 418423. (EL 2)
  • 362
    Nguyen NT, Ho HS, Palmer LS, Wolfe BM. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg 2000; 191: 149157. (EL 3)
  • 363
    Nguyen NT, Ho HS, Fleming NW et al. Cardiac function during laparoscopic vs open gastric bypass. Surg Endosc 2002; 16: 7883. (EL 2)
  • 364
    Marema RT. Laparoscopic Roux-en-Y gastric bypass: a step-by-step approach. J Am Coll Surg 2005; 200: 979982. (EL 4)
  • 365
    Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y: experience of 27 cases, with 3–18 months follow-up. Obes Surg 1996; 6: 5457. (EL 3)
  • 366
    Wittgrove AC, Clark GW, Schubert KR. Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3–30 months follow-up. Obes Surg 1996; 6: 500504. (EL 3)
  • 367
    Marema RT, Perez M, Buffington CK. Comparison of the benefits and complications between laparoscopic and open Roux-en-Y gastric bypass surgeries. Surg Endosc 2005; 19: 525530. (EL 3)
  • 368
    Kim WW, Gagner M, Kini S et al. Laparoscopic vs. open biliopancreatic diversion with duodenal switch: a comparative study. J Gastrointest Surg 2003; 7: 552557. (EL 3)
  • 369
    Benotti PN, Burchard KW, Kelly JJ, Thayer BA. Obesity. Arch Surg 2004; 139: 406414. (EL 4)
  • 370
    Schauer P, Ikramuddin S, Hamad G, Gourash W. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc 2003; 17: 212215. (EL 3)
  • 371
    Shikora SA, Kim JJ, Tarnoff ME, Raskin E, Shore R. Laparoscopic Roux-en-Y gastric bypass: results and learning curve of a high-volume academic program. Arch Surg 2005; 140: 362367. (EL 3)
  • 372
    Ballantyne GH, Ewing D, Capella RF et al. The learning curve measured by operating times for laparoscopic and open gastric bypass: roles of surgeon's experience, institutional experience, body mass index and fellowship training. Obes Surg 2005; 15: 172182. (EL 3)
  • 373
    AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13 (Suppl 1):168. (EL 4)
  • 374
    Vora AC, Saleem TM, Polomano RC et al. Improved perioperative glycemic control by continuous insulin infusion under supervision of an endocrinologist does not increase costs in patients with diabetes. Endocr Pract 2004; 10: 112118. (EL 3)
  • 375
    Pomposelli JJ, Baxter JK III, Babineau TJ et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr 1998; 22: 7781. (EL 3)
  • 376
    American Diabetes Association. Standards of medical care in diabetes—2006 [published correction appears in Diabetes Care 2006; 29: 1192]. Diabetes Care 2006;29(Suppl 1):S4–S42. (EL 4)
  • 377
    Dronge AS, Perkal MF, Kancir S et al. Long-term glycemic control and postoperative infectious complications. Arch Surg 2006; 141: 375380. (EL 3)
  • 378
    Raftopoulos Y, Gagné DJ, Papasavas P et al. Improvement of hypothyroidism after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2004; 14: 509513. (EL 3)
  • 379
    Szomstein S, Avital S, Brasesco O et al. Laparoscopic gastric bypass in patients on thyroid replacement for subnormal thyroid function—prevalence and short-term outcome. Obes Surg 2004; 14: 9597. (EL 3)
  • 380
    de Moraes Moulin CM, Mancini MC, de Melo ME et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005; 15: 12871291. (EL 3)
  • 381
    Helfand M, Redfern CC. Clinical guideline, part 2:screening for thyroid disease; an update. American College of Physicians [published correction appears in Ann Intern Med 1999; 130: 246]. Ann Intern Med 1998;129:144–158. (EL 4)
  • 382
    National Cholesterol Education Program. Third report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): ATP III At-a-glance; Quick Desk Reference <http:www.nhlbi.nih.govguidelinescholesterolatglance.htm> (2002). Accessed 21 April 2008. (EL 4)
  • 383
    Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) [published correction appears in Circulation 2006; 113: e486]. Circulation 2002;105:1257–1267. (EL 4)
  • 384
    Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation 2006; 113: 13611376. (EL 4)
  • 385
    Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 10431049. (EL 2)
  • 386
    US Department of Health&Human Services. Dietary Guidelines for Americans, 2005, Chapter 4 Physical Activity <http:www.health.govdietaryguidelinesdga2005documenthtmlchapter4.htm> (2005). Accessed 22 April 2008. (EL 4)
  • 387
    Kertai MD, Boersma E, Bax JJ et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 13271334. (EL 1)
  • 388
    McGory ML, Maggard MA, Ko CY. A meta-analysis of perioperative beta blockade: what is the actual risk reduction? Surgery 2005; 138: 171179. (EL 1)
  • 389
    US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publication No. 04–5230. <http:www.nhlbi.nih.govguidelineshypertensionjnc7full.pdf> (2004). Accessed 25 April 2008. (EL 4)
  • 390
    Qaseem A, Snow V, Fitterman N et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: a guideline from the American College of Physicians. Ann Intern Med 2006; 144: 575580. (EL 4)
  • 391
    Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg 2007; 205: 248255. (EL 3)
  • 392
    Doyle RL. Assessing and modifying the risk of postoperative pulmonary complications. Chest 1999; 115 (5 Suppl):77S81S. (EL 4)
  • 393
    Smetana GW, Lawrence VA, Cornell JE; American College of Physicians. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144: 581595. (EL 1)
  • 394
    Lautz DB, Jackson TD, Clancy KA et al. Bariatric operations in Veterans Affairs and selected university medical centers: results of the Patient Safety in Surgery Study. J Am Coll Surg 2007; 204: 12611272. (EL 3)
  • 395
    Livingston EH, Arterburn D, Schifftner TL, Henderson WG, DePalma RG. National Surgical Quality Improvement Program analysis of bariatric operations: modifiable risk factors contribute to bariatric surgical adverse outcomes. J Am Coll Surg 2006; 203: 625633. (EL 3)
  • 396
    Geerts WH, Pineo GF, Heit JA et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126 (3 Suppl):338S400S. (EL 4)
  • 397
    Martin LF, Gouda BP. What we know and don't know about deep venous thrombosis and pulmonary embolism! Obes Surg 2005; 15: 565566. (EL 4)
  • 398
    Ogunnaike BO, Jones SB, Jones DB, Provost D, Whitten CW. Anesthetic considerations for bariatric surgery. Anesth Analg 2002; 95: 17931805. (EL 4)
  • 399
    Byrne TK. Complications of surgery for obesity. Surg Clin North Am 2001; 81: 11811193, vii-viii. (EL 4)
  • 400
    Atluri P, Raper SE. Factor V Leiden and postoperative deep vein thrombosis in patients undergoing open Roux-en-Y gastric bypass surgery. Obes Surg 2005; 15: 561564. (EL 3)
  • 401
    Keeling WB, Haines K, Stone PA et al. Current indications for preoperative inferior vena cava filter insertion in patients undergoing surgery for morbid obesity. Obes Surg 2005; 15: 10091012. (EL 3)
  • 402
    Korenkov M, Sauerland S, Shah S, Junginger T. Is routine preoperative upper endoscopy in gastric banding patients really necessary? Obes Surg 2006; 16: 4547. (EL 3)
  • 403
    Yang CS, Lee WJ, Wang HH et al. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg 2006; 16: 735739. (EL 2)
  • 404
    Wang HH, Lee WJ, Liew PL et al. The influence of Helicobacter pylori infection and corpus gastritis on the postoperative outcomes of laparoscopic vertical banded gastroplasty. Obes Surg 2006; 16: 297307. (EL 2)
  • 405
    Ramaswamy A, Lin E, Ramshaw BJ, Smith CD. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg 2004; 139: 10941096. (EL 3)
  • 406
    Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123: 13671384. (EL 4)
  • 407
    Dallal RM, Mattar SG, Lord JL et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 2004; 14: 4753. (EL 3)
  • 408
    Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg 2005; 15: 14811486. (EL 3)
  • 409
    McGoey BV, Deitel M, Saplys RJ, Kliman ME. Effect of weight loss on musculoskeletal pain in the morbidly obese. J Bone Joint Surg 1990; 72: 322323. (EL 3)
  • 410
    Amaral JF, Thompson WR, Caldwell MD, Martin HF, Randall HT. Prospective metabolic evaluation of 150 consecutive patients who underwent gastric exclusion. Am J Surg 1984; 147: 468476. (EL 3)
  • 411
    Starkloff GB, Donovan JF, Ramach KR, Wolfe BM. Metabolic intestinal surgery: its complications and management. Arch Surg 1975; 110: 652657. (EL 3)
  • 412
    Hamoui N, Kim K, Anthone G, Crookes PF. The significance of elevated levels of parathyroid hormone in patients with morbid obesity before and after bariatric surgery. Arch Surg 2003; 138: 891897. (EL 3)
  • 413
    Hamoui N, Anthone G, Crookes PF. Calcium metabolism in the morbidly obese. Obes Surg 2004; 14: 912. (EL 3)
  • 414
    Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pilkington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981; 34: 23592363. (EL 3)
  • 415
    Miller PD. Guidelines for the diagnosis of osteoporosis: T-scores vs fracture. Rev Endocr Metab Disord 2006; 7: 7589. (EL 4)
  • 416
    Levi D, Goodman ER, Patel M, Savransky Y. Critical care of the obese and bariatric surgical patient. Crit Care Clin 2003; 19: 1132. (EL 4)
  • 417
    Stocker DJ. Management of the bariatric surgery patient. Endocrinol Metab Clin North Am 2003; 32: 437457. (EL 4)
  • 418
    Sekhar N, Torquati A, Lutfi R, Richards WO. Endoscopic evaluation of the gastrojejunostomy in laparoscopic gastric bypass: a series of 340 patients without postoperative leak. Surg Endosc 2006; 20: 199201. (EL 2)
  • 419
    Fernandez AZ Jr., DeMaria EJ, Tichansky DS et al. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and related mortality. Surg Endosc 2004; 18: 193197. (EL 3)
  • 420
    Marshall JS, Srivastava A, Gupta SK, Rossi TR, DeBord JR. Roux-en-Y gastric bypass leak complications. Arch Surg 2003; 138: 520523. (EL 3)
  • 421
    Hamilton EC, Sims TL, Hamilton TT et al. Clinical predictors of leak after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Endosc 2003; 17: 679684. (EL 3)
  • 422
    Edwards MA, Jones DB, Ellsmere J, Grinbaum R, Schneider BE. Anastomotic leak following antecolic versus retrocolic laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2007; 17: 292297. (EL 3)
  • 423
    Carucci LR, Turner MA, Conklin RC et al. Roux-en-Y gastric bypass surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology 2006; 238: 119127. (EL 3)
  • 424
    Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y—500 patients: technique and results, with 3–60 month follow-up. Obes Surg 2000; 10: 233239. (EL 2)
  • 425
    Ganci-Cerrud G, Herrera MF. Role of radiologic contrast studies in the early postoperative period after bariatric surgery. Obes Surg 1999; 9: 532534. (EL 3)
  • 426
    Gonzalez R, Sarr MG, Smith CD et al. Diagnosis and contemporary management of anastomotic leaks after gastric bypass for obesity. J Am Coll Surg 2007; 204: 4755. (EL 3)
  • 427
    Brolin RE. Complications of surgery for severe obesity. Prob Gen Surg 2000; 17: 5561. (EL 4)
  • 428
    Toppino M, Cesarani F, Comba A et al. The role of early radiological studies after gastric bariatric surgery. Obes Surg 2001; 11: 447454. (EL 3)
  • 429
    Doherty C. Vertical banded gastroplasty. Surg Clin North Am 2001; 81: 10971112. (EL 4)
  • 430
    Polk HC Jr., Simpson CJ, Simmons BP, Alexander JW. Guidelines for prevention of surgical wound infection. Arch Surg 1983; 118: 12131217. (EL 4)
  • 431
    Polk HC, Jr., Christmas AB. Prophylactic antibiotics in surgery and surgical wound infections. Am Surg 2000; 66: 105111. (EL 4)
  • 432
    Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345: 13591367. (EL 1)
  • 433
    Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354: 449461. (EL 1)
  • 434
    Datta S, Qaadir A, Villanueva G, Baldwin D. Once-daily insulin glargine versus 6-hour sliding scale regular insulin for control of hyperglycemia after a bariatric surgical procedure: a randomized clinical trial. Endocr Pract 2007; 13: 225231. (EL 2)
  • 435
    Garber AJ, Moghissi ES, Bransome ED Jr. et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004; 10 (Suppl 2):49. (EL 4)
  • 436
    McDonnell ME, Apovian CM, Hess DT Jr. Medical management of the patient after gastric-bypass surgery. In: Farraye FA, Forse RA (eds). Bariatric Surgery: A Primer for Your Medical Practice. SLACK Incorporated: Thorofare, NJ, 2006, pp 157181. (EL 4)
  • 437
    Residori L, García-Lorda P, Flancbaum L, Pi-Sunyer FX, Laferrère B. Prevalence of co-morbidities in obese patients before bariatric surgery: effect of race. Obes Surg 2003; 13: 333340. (EL 3)
  • 438
    Pope GD, Birkmeyer JD, Finlayson SR. National trends in utilization and in-hospital outcomes of bariatric surgery. J Gastrointest Surg 2002; 6: 855860. (EL 3)
  • 439
    Nanji AA, Freeman JB. Rate of weight loss after vertical banded gastroplasty in morbid obesity: relationship to serum lipids and uric acid. Int Surg 1985; 70: 323325. (EL 3)
  • 440
    Kelly TM, Jones SB. Changes in serum lipids after gastric bypass surgery: lack of a relationship to weight loss. Int J Obes 1986; 10: 443452. (EL 3)
  • 441
    Gleysteen JJ, Barboriak JJ, Sasse EA. Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr 1990; 51: 774778. (EL 3)
  • 442
    Brolin RE, Kenler HA, Wilson AC, Kuo PT, Cody RP. Serum lipids after gastric bypass surgery for morbid obesity. Int J Obes 1990; 14: 939950. (EL 3)
  • 443
    Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML, Sarr MG, Somers VK. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc 2005; 80: 11571162. (EL 3)
  • 444
    Alpert MA, Hashimi MW. Obesity and the heart. Am J Med Sci 1993; 306: 117123. (EL 4)
  • 445
    Backman L, Freyschuss U, Hallberg D, Melcher A. Cardiovascular function in extreme obesity. Acta Med Scand 1973; 193: 437446. (EL 3)
  • 446
    Lawrence VA, Hilsenbeck SG, Mulrow CD et al. Incidence and hospital stay for cardiac and pulmonary complications after abdominal surgery. J Gen Intern Med 1995; 10: 671678. (EL 2)
  • 447
    Blouw EL, Rudolph AD, Narr BJ, Sarr MG. The frequency of respiratory failure in patients with morbid obesity undergoing gastric bypass. AANA J 2003; 71: 4550. (EL 3)
  • 448
    Oberg B, Poulsen TD. Obesity: an anaesthetic challenge. Acta Anaesthesiol Scand 1996; 40: 191200. (EL 4)
  • 449
    Marik P, Varon J. The obese patient in the ICU. Chest 1998; 113: 492498. (EL 4)
  • 450
    Torrington KG, Sorenson DE, Sherwood LM. Postoperative chest percussion with postural drainage in obese patients following gastric stapling. Chest 1984; 86: 891895. (EL 3)
  • 451
    Huerta S, DeShields S, Shpiner R et al. Safety and efficacy of postoperative continuous positive airway pressure to prevent pulmonary complications after Roux-en-Y gastric bypass. J Gastrointest Surg 2002; 6: 354358. (EL 2)
  • 452
    Schumann R, Jones SB, Ortiz VE et al. Best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery. Obes Res 2005; 13: 254266. (EL 3)
  • 453
    Sugerman HJ, Kellum JM, Engle KM et al. Gastric bypass for treating severe obesity. Am J Clin Nutr 1992; 55 (2 Suppl):560S566S. (EL 4)
  • 454
    Fobi MA, Lee H, Igwe D Jr., Stanczyk M, Tambi JN. Prospective comparative evaluation of stapled versus transected Silastic ring gastric bypass: 6-year follow-up. Obes Surg 2001; 11: 1824. (EL 2)
  • 455
    Capan LM, Miller SM. Monitoring for suspected pulmonary embolism. Anesthesiol Clin North Am 2001; 19: 673703. (EL 4)
  • 456
    Scholten DJ, Hoedema RM, Scholten SE. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg 2002; 12: 1924. (EL 3)
  • 457
    Kalfarentzos F, Stavropoulou F, Yarmenitis S et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 2001; 11: 670676. (EL 2)
  • 458
    Miller MT, Rovito PF. An approach to venous thromboembolism prophylaxis in laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg 2004; 14: 731737. (EL 3)
  • 459
    Ferrell A, Byrne TK, Robison JG. Placement of inferior vena cava filters in bariatric surgical patients—possible indications and technical considerations. Obes Surg 2004; 14: 738743. (EL 3)
  • 460
    Mognol P, Vignes S, Chosidow D, Marmuse JP. Rhabdomyolysis after laparoscopic bariatric surgery. Obes Surg 2004; 14: 9194. (EL 3)
  • 461
    de Freitas, Carvalho DA, Valezi AC, de Brito EM et al. Rhabdomyolysis after bariatric surgery. Obes Surg 2006; 16: 740744. (EL 3)
  • 462
    Yeats M, Wedergren S, Fox N, Thompson JS. The use and modification of clinical pathways to achieve specific outcomes in bariatric surgery. Am Surg 2005; 71: 152154. (EL 3)
  • 463
    Huerta S, Arteaga JR, Sawicki MP, Liu CD, Livingston EH. Assessment of routine elimination of postoperative nasogastric decompression after Roux-en-Y gastric bypass. Surgery 2002; 132: 844848. (EL 3)
  • 464
    Kushner R. Managing the obese patient after bariatric surgery: a case report of severe malnutrition and review of the literature. JPEN J Parenter Enteral Nutr 2000; 24: 126132. (EL 3)
  • 465
    Wolf AM, Kortner B, Kuhlmann HW. Results of bariatric surgery. Int J Obes Relat Metab Disord 2001; 25 (Suppl 1):S113S114. (EL 3)
  • 466
    Sugerman HJ, Kellum JM Jr., DeMaria EJ, Reines HD. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg 1996; 171: 263269. (EL 3)
  • 467
    Kim TH, Daud A, Ude AO et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc 2006; 20: 202209. (EL 3)
  • 468
    Metcalf B, Rabkin RA, Rabkin JM, Metcalf LJ, Lehman-Becker LB. Weight loss composition: the effects of exercise following obesity surgery as measured by bioelectrical impedance analysis. Obes Surg 2005; 15: 183186. (EL 3)
  • 469
    Shen R, Dugay G, Rajaram K et al. Impact of patient follow-up on weight loss after bariatric surgery. Obes Surg 2004; 14: 514519. (EL 3)
  • 470
    Favretti F, O'Brien PE, Dixon JB. Patient management after LAP-BAND placement. Am J Surg 2002; 184: 38S41S. (EL 4)
  • 471
    Dixon AF, Dixon JB, O'Brien PE. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 2005; 90: 813819. (EL 3)
  • 472
    Dixon JB, O'Brien PE. Permeability of the silicone membrane in laparoscopic adjustable gastric bands has important clinical implications. Obes Surg 2005; 15: 624629. (EL 3)
  • 473
    Dixon JB, Dixon ME, O'Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003; 163: 20582065. (EL 3)
  • 474
    Pories WJ, MacDonald KG, Swanson MS et al. Staple-line failure: an avoidable complication of the gastric bypass. Obes Surg 1993; 3: 95. (EL 3)
  • 475
    MacLean LD, Rhode BM, Nohr C, Katz S, McLean AP. Stomal ulcer after gastric bypass. J Am Coll Surg 1997; 185: 17. (EL 3)
  • 476
    Lublin M, McCoy M, Waldrep DJ. Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc 2006; 20: 5154. (EL 3)
  • 477
    MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg 2000; 231: 524528. (EL 3)
  • 478
    Deitel M. Overview of operations for morbid obesity. World J Surg 1998; 22: 913918. (EL 4)
  • 479
    Deitel M, Shahi B. Morbid obesity: selection of patients for surgery. J Am Coll Nutr 1992; 11: 457462. (EL 4)
  • 480
    Olbers T, Fagevik-Olsén M, Maleckas A, Lönroth H. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg 2005; 92: 557562. (EL 2)
  • 481
    Lechner GW, Callender AK. Subtotal gastric exclusion and gastric partitioning: a randomized prospective comparison of one hundred patients. Surgery 1981; 90: 637644. (EL 2)
  • 482
    Näslund I. The size of the gastric outlet and the outcome of surgery for obesity. Acta Chir Scand 1986; 152: 205210. (EL 2)
  • 483
    Pories WJ, Flickinger EG, Meelheim D, Van Rij AM, Thomas FT. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Ann Surg 1982; 196: 389399. (EL 2)
  • 484
    Marceau P, Biron S, Hould FS, Lebel S, Marceau S. Malabsorptive procedure in surgical treatment of morbid obesity. Prob Gen Surg 2000; 17: 2939. (EL 4)
  • 485
    Lee WJ, Huang MT, Yu PJ, Wang W, Chen TC. Laparoscopic vertical banded gastroplasty and laparoscopic gastric bypass: a comparison. Obes Surg 2004; 14: 626634. (EL 2)
  • 486
    Morino M, Toppino M, Bonnet G, del Genio G. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 2003; 238: 835841. (EL 2)
  • 487
    Watkins BM, Montgomery KF, Ahroni JH. Laparoscopic adjustable gastric banding: early experience in 400 consecutive patients in the USA. Obes Surg 2005; 15: 8287. (EL 2)
  • 488
    Murr MM, Balsiger BM, Kennedy FP, Mai JL, Sarr MG. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg 1999; 3: 607612. (EL 3)
  • 489
    Guedea ME, del Amo Arribas D, Solanas JA et al. Results of biliopancreatic diversion after five years. Obes Surg 2004; 14: 766772. (EL 3)
  • 490
    Nelson WK, Fatima J, Houghton SG et al. The malabsorptive very, very long limb Roux-en-Y gastric bypass for super obesity: results in 257 patients [with discussion]. Surgery 2006; 140: 517523. (EL 3)
  • 491
    Bock MA. Roux-en-Y gastric bypass: the dietitian's and patient's perspectives. Nutr Clin Pract 2003; 18: 141144. (EL 4)
  • 492
    Collene A, Hertzler S. Metabolic outcomes of gastric bypass. Nutr Clin Pract 2003; 18: 136140. (EL 4)
  • 493
    Shamblin JR, Shamblin WR. Bariatric surgery should be more widely accepted. South Med J 1987; 80: 861865. (EL 4)
  • 494
    Brolin RL, Robertson LB, Kenler HA, Cody RP. Weight loss and dietary intake after vertical banded gastroplasty and Roux-en-Y gastric bypass. Ann Surg 1994; 220: 782790. (EL 3)
  • 495
    Lagacé M, Marceau P, Marceau S et al. Biliopancreatic diversion with a new type of gastrectomy: some previous conclusions revisited. Obes Surg 1995; 5: 411418. (EL 3)
  • 496
    Brolin RE, Gorman RC, Milgrim LM, Kenler HA. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes 1991; 15: 661667. (EL 3)
  • 497
    Skroubis G, Sakellaropoulos G, Pouggouras K et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551558. (EL 3)
  • 498
    Compston JE, Vedi S, Gianetta E et al. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology 1984; 87: 350356. (EL 3)
  • 499
    Marceau P, Biron S, Lagacé M et al. Biliopancreatic diversion, with distal gastrectomy, 250 cm and 50 cm limbs: long-term results. Obes Surg 1995; 5: 302307. (EL 3)
  • 500
    Monteforte MJ, Turkelson CM. Bariatric surgery for morbid obesity. Obes Surg 2000; 10: 391401. (EL 1)
  • 501
    Mallory GN, Macgregor AM, Rand CS. The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 1996; 6: 474478. (EL 3)
  • 502
    Didden P, Penning C, Masclee AA. Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment Pharmacol Ther 2006; 24: 13671375. (EL 3)
  • 503
    Balsiger BM, Kennedy FP, Abu-Lebdeh HS et al. Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc 2000; 75: 673680. (EL 2)
  • 504
    Ukleja A. Dumping syndrome: pathophysiology and treatment. Nutr Clin Pract 2005; 20: 517525. (EL 4)
  • 505
    Carvajal SH, Mulvihill SJ. Postgastrectomy syndromes: dumping and diarrhea. Gastroenterol Clin North Am 1994; 23: 261279. (EL 4)
  • 506
    Service GJ, Thompson GB, Service FJ et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 2005; 353: 249254. (EL 3)
  • 507
    Patti ME, McMahon G, Mun EC et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 2005; 48: 22362240. (EL 3)
  • 508
    Avinoah E, Ovnat A, Charuzi I. Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery 1992; 111: 137142. (EL 3)
  • 509
    Moize V, Geliebter A, Gluck ME et al. Obese patients have inadequate protein intake related to protein intolerance up to 1 year following Roux-en-Y gastric bypass. Obes Surg 2003; 13: 2328. (EL 3)
  • 510
    Stunkard A, Foster G, Glassman J, Rosato E. Retrospective exaggeration of symptoms: vomiting after gastric surgery for obesity. Psychosom Med 1985; 47: 150155. (EL 3)
  • 511
    Brolin RE, Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg 1999; 9: 150154. (EL 3)
  • 512
    Crowley LV, Seay J, Mullin G. Late effects of gastric bypass for obesity. Am J Gastroenterol 1984; 79: 850860. (EL 3)
  • 513
    Saltzman E, Anderson W, Apovian CM et al. Criteria for patient selection and multidisciplinary evaluation and treatment of the weight loss surgery patient. Obes Res 2005; 13: 234243. (EL 4)
  • 514
    Amaral JF, Thompson WR, Caldwell MD, Martin HF, Randall HT. Prospective hematologic evaluation of gastric exclusion surgery for morbid obesity. Ann Surg 1985; 201: 186193. (EL 2)
  • 515
    Faintuch J, Matsuda M, Cruz ME et al. Severe protein-calorie malnutrition after bariatric procedures. Obes Surg 2004; 14: 175181. (EL 3)
  • 516
    Chang CG, Adams-Huet B, Provost DA. Acute post-gastric reduction surgery (APGARS) neuropathy. Obes Surg 2004; 14: 182189. (EL 3)
  • 517
    Akhtar M, Collins MP, Kissel JT. Acute postgastric reduction surgery (APGARS) neuropathy: a polynutritional, multisystem disorder [abstract]. Neurology 2002; 58 (Suppl 3):A68A69. (EL 3)
  • 518
    Nanni G, Balduzzi GF, Capoluongo R et al. Biliopancreatic diversion: clinical experience. Obes Surg 1997; 7: 2629. (EL 3)
  • 519
    Marinari GM, Murelli F, Camerini G et al. A 15-year evaluation of biliopancreatic diversion according to the Bariatric Analysis Reporting Outcome System (BAROS). Obes Surg 2004; 14: 325328. (EL 3)
  • 520
    Kalfarentzos F, Dimakopoulos A, Kehagias I, Loukidi A, Mead N. Vertical banded gastroplasty versus standard or distal Roux-en-Y gastric bypass based on specific selection criteria in the morbidly obese: preliminary results. Obes Surg 1999; 9: 433442. (EL 3)
  • 521
    Vanuytsel JL, Nobels FR, Van Gaal LF, De Leeuw IH. A case of malnutrition after biliopancreatic diversion for morbid obesity. Int J Obes Relat Metab Disord 1993; 17: 425426. (EL 3)
  • 522
    Strauss BJ, Marks SJ, Growcott JP et al. Body composition changes following laparoscopic gastric banding for morbid obesity. Acta Diabetol 2003; 40 (Suppl 1):S266S269. (EL 3)
  • 523
    Dixon JB, Strauss BJ, Laurie C, O'Brien PE. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring) 2007; 15: 11871198. (EL 2)
  • 524
    Ott MT, Fanti P, Malluche HH et al. Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity. Obes Surg 1992; 2: 341348. (EL 3)
  • 525
    Shaker JL, Norton AJ, Woods MF, Fallon MD, Findling JW. Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity. Osteoporos Int 1991; 1: 177181. (EL 3)
  • 526
    Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan LS. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004; 89: 10611065. (EL 2)
  • 527
    Charles P. Calcium absorption and calcium bioavailability. J Intern Med 1992; 231: 161168. (EL 4)
  • 528
    Pugnale N, Giusti V, Suter M et al. Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women. Int J Obes Relat Metab Disord 2003; 27: 110116. (EL 3)
  • 529
    Alborzi F, Leibowitz AB. Immobilization hypercalcemia in critical illness following bariatric surgery. Obes Surg 2002; 12: 871873. (EL 3)
  • 530
    Liel Y, Edwards J, Shary J et al. The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab 1988; 66: 12471250. (EL 2)
  • 531
    Gossain VV, Rao DS, Carella MJ, Divine G, Rovner DR. Bone mineral density (BMD) in obesity: effect of weight loss. J Med 1999; 30: 367376. (EL 3)
  • 532
    Bell NH, Epstein S, Greene A et al. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370373. (EL 3)
  • 533
    Fu L, Patel MS, Bradley A, Wagner EF, Karsenty G. The molecular clock mediates leptin-regulated bone formation. Cell 2005; 122: 803815. (EL 4)
  • 534
    De Prisco C, Levine SN. Metabolic bone disease after gastric bypass surgery for obesity. Am J Med Sci 2005; 329: 5761. (EL 3)
  • 535
    Goode LR, Brolin RE, Chowdhury HA, Shapses SA. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes Res 2004; 12: 4047. (EL 2)
  • 536
    Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002; 77: 453468. (EL 4)
  • 537
    Diniz MdeF, Diniz MT, Sanches SR et al. Elevated serum parathormone after Roux-en-Y gastric bypass. Obes Surg 2004; 14: 12221226. (EL 3)
  • 538
    Parada P, Maruri I, Morales MJ et al. Nutritional complications after bariatric surgery [abstract 33]. Obes Surg 2003; 13: 525. (EL 3)
  • 539
    Youssef Y, Richards WO, Sekhar N et al. Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women. Surg Endosc 2007; 21: 13931396. (EL 2)
  • 540
    Slater GH, Ren CJ, Siegel N et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg 2004; 8: 4855. (EL 3)
  • 541
    Newbury L, Dolan K, Hatzifotis M, Low N, Fielding G. Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion. Obes Surg 2003; 13: 893895. (EL 3)
  • 542
    Reidt CS, Brolin RE, Sherrell RM, Field MP, Shapses SA. True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 2006; 14: 19401948. (EL 3)
  • 543
    Johnson JM, Maher JW, Samuel I et al. Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D [with discussion]. J Gastrointest Surg 2005; 9: 11061111. (EL 2)
  • 544
    Bloomberg RD, Fleischman A, Nalle JE, Herron DM, Kini S. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 2005; 15: 145154. (EL 4)
  • 545
    Shikora SA, Kim JJ, Tarnoff ME. Nutrition and gastrointestinal complications of bariatric surgery. Nutr Clin Pract 2007; 22: 2940. (EL 4)
  • 546
    Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health Syst Pharm 2006; 63: 18521857. (EL 4)
  • 547
    Levenson DI, Bockman RS. A review of calcium preparations [published correction appears in Nutr Rev 1994; 52: 364]. Nutr Rev 1994;52:221–232. (EL 4)
  • 548
    Dawson-Hughes B. Calcium and vitamin D. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th edn. American Society for Bone and Mineral Research: Washington, DC, 2006, pp 257259. (EL 4)
  • 549
    Ybarra J, Sánchez-Hernández J, Gich I et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg 2005; 15: 330335. (EL 3)
  • 550
    Sánchez-Hernández J, Ybarra J, Gich I et al. Effects of bariatric surgery on vitamin D status and secondary hyperparathyroidism: a prospective study. Obes Surg 2005; 15: 13891395. (EL 2)
  • 551
    Rojas-Marcos PM, Rubio MA, Kreskshi WI, Cabrerizo L, Sánchez-Pernaute A. Severe hypocalcemia following total thyroidectomy after biliopancreatic diversion. Obes Surg 2005; 15: 431434. (EL 3)
  • 552
    Marceau P, Biron S, Lebel S et al. Does bone change after biliopancreatic diversion? J Gastrointest Surg 2002; 6: 690698. (EL 2)
  • 553
    Mitchell DY, Eusebio RA, Dunlap LE et al. Risedronate gastrointestinal absorption is independent of site and rate of administration. Pharm Res 1998; 15: 228232. (EL 3)
  • 554
    Lanza FL, Hunt RH, Thomson AB, Provenza JM, Blank MA. Endoscopic comparison of esophageal and gastroduodenal effects of risedronate and alendronate in postmenopausal women. Gastroenterology 2000; 119: 631638. (EL 3)
  • 555
    Maricic M. New and emerging treatments for osteoporosis. Curr Opin Rheumatol 2007; 19: 364369. (EL 4)
  • 556
    Rosen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 2003; 348: 15031504. (EL 3)
  • 557
    Collazo-Clavell ML, Jimenez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 2004; 10: 195198. (EL 3)
  • 558
    Duncan SH, Richardson AJ, Kaul P et al. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 2002; 68: 38413847. (EL 4)
  • 559
    Campieri C, Campieri M, Bertuzzi V et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001; 60: 10971105. (EL 3)
  • 560
    Lieske JC, Goldfarb DS, De Simone C, Regnier C. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 2005; 68: 12441249. (EL 3)
  • 561
    Spencer H, Lesniak M, Gatza CA, Osis D, Lender M. Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function. Gastroenterology 1980; 79: 2634. (EL 3)
  • 562
    Chassany O, Michaux A, Bergmann JF. Drug-induced diarrhoea. Drug Saf 2000; 22: 5372. (EL 4)
  • 563
    New York State Osteoporosis Prevention and Education Program. Phosphorus <http:www.nysopep.orgPrevention_Phosphorus.shtm> (2004). Accessed 25 April 2008. (EL 4)
  • 564
    Apovian CM, McMahon MM, Bistrian BR. Guidelines for refeeding the marasmic patient. Crit Care Med 1990; 18: 10301033. (EL 4)
  • 565
    Food and Agriculture Organization World Health Organization. Fat in Human Nutrition: Report of an Expert Consultation. Publications Division, Food and Agriculture Organization: Rome, Italy, 1993. (EL 4)
  • 566
    Innis SM. Essential dietary lipids. In: Ziegler EE, Filer LJ Jr. (eds). Present Knowledge in Nutrition, 7th edn. ILSI Press: Washington, DC, 1996, pp 5866. (EL 4)
  • 567
    Smit EN, Muskiet FA, Boersma ER. The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 241250. (EL 4)
  • 568
    Miller DG, Williams SK, Palombo JD et al. Cutaneous application of safflower oil in preventing essential fatty acid deficiency in patients on home parenteral nutrition. Am J Clin Nutr 1987; 46: 419423. (EL 3)
  • 569
    Bradley JE, Brown RO, Luther RW. Multiple nutritional deficiencies and metabolic complications 20 years after jejunoileal bypass surgery. JPEN J Parenter Enteral Nutr 1987; 11: 494498. (EL 3)
  • 570
    Halverson JD, Scheff RJ, Gentry K, Alpers DH. Long-term follow-up of jejunoileal bypass patients. Am J Clin Nutr 1980; 33 (2 Suppl):472475. (EL 3)
  • 571
    Rogers EL, Douglass W, Russell RM et al. Deficiency of fat soluble vitamins after jejunoileal bypass surgery for morbid obesity. Am J Clin Nutr 1980; 33: 12081214. (EL 3)
  • 572
    Kaneki M, Hosoi T, Ouchi Y, Orimo H. Pleiotropic actions of vitamin K: protector of bone health and beyond? Nutrition 2006; 22: 845852. (EL 4)
  • 573
    Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988; 48: 612619. (EL 4)
  • 574
    Skroubis G, Anesidis S, Kehagias I et al. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg 2006; 16: 488495. (EL 2)
  • 575
    Brolin RE, Gorman JH, Gorman RC et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg 1998; 133: 740744. (EL 2)
  • 576
    Rhode BM, Shustik C, Christou NV, MacLean LD. Iron absorption and therapy after gastric bypass. Obes Surg 1999; 9: 1721. (EL 3)
  • 577
    Beard JL, Dawson H, Piñero DJ. Iron metabolism: a comprehensive review. Nutr Rev 1996; 54: 295317. (EL 4)
  • 578
    Lash A, Saleem A. Iron metabolism and its regulation: a review. Ann Clin Lab Sci 1995; 25: 2030. (EL 4)
  • 579
    Herbert V. Absorption of vitamin B12 and folic acid. Gastroenterology 1968; 54: 110115. (EL 4)
  • 580
    Fondu P, Hariga-Muller C, Mozes N et al. Protein-energy malnutrition and anemia in Kivu. Am J Clin Nutr 1978; 31: 4656. (EL 4)
  • 581
    Hallberg L, Brune M, Erlandsson M, Sandberg AS, Rossander-Hultén L. Calcium: effect of different amounts on nonheme- and heme-iron absorption in humans. Am J Clin Nutr 1991; 53: 112119. (EL 3)
  • 582
    Cook JD, Dassenko SA, Whittaker P. Calcium supplementation: effect on iron absorption. Am J Clin Nutr 1991; 53: 106111. (EL 3)
  • 583
    Reddy MB, Cook JD. Effect of calcium intake on nonheme-iron absorption from a complete diet. Am J Clin Nutr 1997; 65: 18201825. (EL 3)
  • 584
    Halverson JD. Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg 1986; 52: 594598. (EL 3)
  • 585
    Smith CD, Herkes SB, Behrns KE et al. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg 1993; 218: 9196. (EL 3)
  • 586
    Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci 1994; 39: 315320. (EL 3)
  • 587
    Provenzale D, Reinhold RB, Golner B et al. Evidence for diminished B12 absorption after gastric bypass: oral supplementation does not prevent low plasma B12 levels in bypass patients. J Am Coll Nutr 1992; 11: 2935. (EL 3)
  • 588
    Marcuard SP, Sinar DR, Swanson MS, Silverman JF, Levine JS. Absence of luminal intrinsic factor after gastric bypass surgery for morbid obesity. Dig Dis Sci 1989; 34: 12381242. (EL 3)
  • 589
    Cooper PL, Brearley LK, Jamieson AC, Ball MJ. Nutritional consequences of modified vertical gastroplasty in obese subjects. Int J Obes Relat Metab Disord 1999; 23: 382388. (EL 3)
  • 590
    Rhode BM, Tamin H, Gilfix BM et al. Treatment of vitamin B12 deficiency after gastric surgery for severe obesity. Obes Surg 1995; 5: 154158. (EL 3)
  • 591
    Rhode BM, Arseneau P, Cooper BA et al. Vitamin B-12 deficiency after gastric surgery for obesity. Am J Clin Nutr 1996; 63: 103109. (EL 3)
  • 592
    Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998; 92: 11911198. (EL 2)
  • 593
    Clements RH, Katasani VG, Palepu R et al. Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg 2006; 72: 11961202. (EL 3)
  • 594
    Mejia LA. Role of vitamin A in iron deficiency anemia. In: Fomon SJ, Zlotkin S (eds). Nutritional Anemias. Raven: New York, 1992, pp 93104. (EL 4)
  • 595
    Shaw JC. Copper deficiency in term and preterm infants. In: Fomon SJ, Zlotkin S (eds). Nutritional Anemias. Raven: New York, 1992, pp 105120. (EL 4)
  • 596
    Todd LM, Godber IM, Gunn IR. Iatrogenic copper deficiency causing anaemia and neutropenia. Ann Clin Biochem 2004; 41: 414416. (EL 3)
  • 597
    Nagano T, Toyoda T, Tanabe H et al. Clinical features of hematological disorders caused by copper deficiency during long-term enteral nutrition. Intern Med 2005; 44: 554559. (EL 3)
  • 598
    Sharp P. The molecular basis of copper and iron interactions. Proc Nutr Soc 2004; 63: 563569. (EL 4)
  • 599
    Kumar N, Ahlskog JE, Gross JB Jr. Acquired hypocupremia after gastric surgery. Clin Gastroenterol Hepatol 2004; 2: 10741079. (EL 3)
  • 600
    King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr 2000; 130 (5S Suppl):1360S1366S. (EL 4)
  • 601
    McMillan DC, Sattar N, Talwar D, O'Reilly DS, McArdle CS. Changes in micronutrient concentrations following anti-inflammatory treatment in patients with gastrointestinal cancer. Nutrition 2000; 16: 425428. (EL 3)
  • 602
    Hambidge KM. Zinc and diarrhea. Acta Paediatr Suppl 1992; 381: 8286. (EL 4)
  • 603
    Vanderhoof JA, Scopinaro N, Tuma DJ et al. Hair and plasma zinc levels following exclusion of biliopancreatic secretions from functioning gastrointestinal tract in humans. Dig Dis Sci 1983; 28: 300305. (EL 3)
  • 604
    Willis MS, Monaghan SA, Miller ML et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol 2005; 123: 125131. (EL 3)
  • 605
    Jeejeebhoy KN. Human zinc deficiency. Nutr Clin Pract 2007; 22: 6567. (EL 4)
  • 606
    Angstadt JD, Bodziner RA. Peripheral polyneuropathy from thiamine deficiency following laparoscopic Roux-en-Y gastric bypass. Obes Surg 2005; 15: 890892. (EL 3)
  • 607
    Shuster MH, Vázquez JA. Nutritional concerns related to Roux-en-Y gastric bypass: what every clinician needs to know. Crit Care Nurs Q 2005; 28: 227260. (EL 4)
  • 608
    Carrodeguas L, Kaidar-Person O, Szomstein S, Antozzi P, Rosenthal R. Preoperative thiamine deficiency in obese population undergoing laparoscopic bariatric surgery. Surg Obes Relat Dis 2005; 1: 517522. (EL 3)
  • 609
    Gollobin C, Marcus WY. Bariatric beriberi. Obes Surg 2002; 12: 309311. (EL 4)
  • 610
    Mason EE. Starvation injury after gastric reduction for obesity. World J Surg 1998; 22: 10021007. (EL 4)
  • 611
    MacLean LD, Rhode BM, Shizgal HM. Nutrition following gastric operations for morbid obesity. Ann Surg 1983; 198: 347355. (EL 3)
  • 612
    Feit H, Glasberg M, Ireton C, Rosenberg RN, Thal E. Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med 1982; 96: 453455. (EL 3)
  • 613
    Fawcett S, Young GB, Holliday RL. Wernicke's encephalopathy after gastric partitioning for morbid obesity. Can J Surg 1984; 27: 169170. (EL 3)
  • 614
    Villar HV, Ranne RD. Neurologic deficit following gastric partitioning: possible role of thiamine. JPEN J Parenter Enteral Nutr 1984; 8: 575578. (EL 3)
  • 615
    Somer H, Bergström L, Mustajoki P, Rovamo L. Morbid obesity, gastric plication and a severe neurological deficit. Acta Med Scand 1985; 217: 575576. (EL 3)
  • 616
    Paulson GW, Martin EW, Mojzisik C, Carey LC. Neurologic complications of gastric partitioning. Arch Neurol 1985; 42: 675677. (EL 3)
  • 617
    Oczkowski WJ, Kertesz A. Wernicke's encephalopathy after gastroplasty for morbid obesity. Neurology 1985; 35: 99101. (EL 3)
  • 618
    Abarbanel JM, Berginer VM, Osimani A, Solomon H, Charuzi I. Neurologic complications after gastric restriction surgery for morbid obesity. Neurology 1987; 37: 196200. (EL 3)
  • 619
    Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review. Neurology 2007; 68: 807811. (EL 4)
  • 620
    Chaves LC, Faintuch J, Kahwage S, Alencar Fde A. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg 2002; 12: 328334. (EL 3)
  • 621
    Primavera A, Brusa G, Novello P et al. Wernicke-Korsakoff encephalopathy following biliopancreatic diversion. Obes Surg 1993; 3: 175177. (EL 3)
  • 622
    Rindi G, Bordi C, Rappel S et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996; 20: 168172. (EL 3)
  • 623
    Heye N, Terstegge K, Sirtl C et al. Wernicke's encephalopathy—causes to consider. Intensive Care Med 1994; 20: 282286. (EL 4)
  • 624
    Melissas J, Christodoulakis M, Schoretsanitis G et al. Obesity-associated disorders before and after weight reduction by vertical banded gastroplasty in morbidly vs super obese individuals. Obes Surg 2001; 11: 475481. (EL 3)
  • 625
    Adami GF, Papadia F, Carlini F, Murelli F, Scopinaro N. Effect of biliopancreatic diversion on hypertension in severely obese patients. Hypertens Res 2005; 28: 119123. (EL 3)
  • 626
    Valera-Mora ME, Simeoni B, Gagliardi L et al. Predictors of weight loss and reversal of comorbidities in malabsorptive bariatric surgery. Am J Clin Nutr 2005; 81: 12921297. (EL 3)
  • 627
    Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity: late follow-up in 100 cases. N Engl J Med 1983; 308: 995999. (EL 3)
  • 628
    Armbrecht U, Lundell L, Lindstedt G, Stockbruegger RW. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand 1988; 154: 3741. (EL 3)
  • 629
    Teo M, Chung S, Chitti L et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastroenterol Hepatol 2004; 19: 904909. (EL 3)
  • 630
    Ransford RA, Hayes M, Palmer M, Hall MJ. A controlled, prospective screening study of celiac disease presenting as iron deficiency anemia. J Clin Gastroenterol 2002; 35: 228233. (EL 3)
  • 631
    Scoglio R, Di Pasquale G, Pagano G et al. Is intestinal biopsy always needed for diagnosis of celiac disease? Am J Gastroenterol 2003; 98: 13251331. (EL 3)
    Direct Link:
  • 632
    Murray JA, Watson T, Clearman B, Mitros F. Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr 2004; 79: 669673. (EL 3)
  • 633
    Wahab PJ, Meijer JW, Mulder CJ. Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery. Am J Clin Pathol 2002; 118: 459463. (EL 3)
  • 634
    Podnos YD, Jimenez JC, Wilson SE, Stevens CM, Nguyen NT. Complications after laparoscopic gastric bypass: a review of 3464 cases. Arch Surg 2003; 138: 957961. (EL 4)
  • 635
    Huang CS, Forse RA, Jacobson BC, Farraye FA. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc 2003; 58: 859866. (EL 3)
  • 636
    Livingston EH. Complications of bariatric surgery. Surg Clin North Am 2005; 85: 853868. (EL 4)
  • 637
    Nemni J. Severe chronic cough after Lap-Band gastric surgery. Can Respir J 2007; 14: 171172. (EL 3)
  • 638
    Gentil B, Etienne-Mastroïanni B, Cordier JF. Chronic cough after laparoscopic adjustable gastric banding [article in French]. Rev Mal Respir 2003; 20: 451454. (EL 3)
  • 639
    Jones KB. Biliopancreatic limb obstruction in gastric bypass at or proximal to the jejunojejunostomy: a potentially deadly, catastrophic event. Obes Surg 1996; 6: 485493. (EL 3)
  • 640
    Champion JK, Williams M. Small bowel obstruction and internal hernias after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2003; 13: 596600. (EL 3)
  • 641
    Nelson LG, Gonzalez R, Haines K, Gallagher SF, Murr MM. Spectrum and treatment of small bowel obstruction after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 377383. (EL 3)
  • 642
    Ahmed AR, O'Malley W. Internal hernia with Roux loop obstruction during pregnancy after gastric bypass surgery. Obes Surg 2006; 16: 12461248. (EL 4)
  • 643
    Charles A, Domingo S, Goldfadden A et al. Small bowel ischemia after Roux-en-Y gastric bypass complicated by pregnancy: a case report. Am Surg 2005; 71: 231234. (EL 3)
  • 644
    Kakarla N, Dailey C, Marino T, Shikora SA, Chelmow D. Pregnancy after gastric bypass surgery and internal hernia formation. Obstet Gynecol 2005; 105: 11951198. (EL 3)
  • 645
    Dittrick GW, Thompson JS, Campos D, Bremers D, Sudan D. Gallbladder pathology in morbid obesity. Obes Surg 2005; 15: 238242. (EL 3)
  • 646
    Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995; 98: 115117. (EL 4)
  • 647
    Wudel LJ Jr., Wright JK, Debelak JP et al. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 2002; 102: 5056. (EL 2)
  • 648
    O'Brien PE, Dixon JB. A rational approach to cholelithiasis in bariatric surgery: its application to the laparoscopically placed adjustable gastric band. Arch Surg 2003; 138: 908912. (EL 3)
  • 649
    Shiffman ML, Sugerman HJ, Kellum JH, Brewer WH, Moore EW. Gallstones in patients with morbid obesity: relationship to body weight, weight loss and gallbladder bile cholesterol solubility. Int J Obes Relat Metab Disord 1993; 17: 153158. (EL 3)
  • 650
    Sugerman HJ, Brewer WH, Shiffman ML et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric bypass-induced rapid weight loss [with discussion]. Am J Surg 1995; 169: 9197. (EL 1)
  • 651
    Fobi M, Lee H, Igwe D et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg 2002; 12: 350353. (EL 3)
  • 652
    Villegas L, Schneider B, Provost D et al. Is routine cholecystectomy required during laparoscopic gastric bypass? Obes Surg 2004; 14: 206211. (EL 3)
  • 653
    Ellner SJ, Myers TT, Piorkowski JR, Mavanur AA, Barba CA. Routine cholecystectomy is not mandatory during morbid obesity surgery. Surg Obes Relat Dis 2007; 3: 456460. (EL 3)
  • 654
    Riordan SM, McIver CJ, Duncombe VM, Thomas MC, Bolin TD. Evaluation of the rice breath hydrogen test for small intestinal bacterial overgrowth. Am J Gastroenterol 2000; 95: 28582864. (EL 3)
    Direct Link:
  • 655
    Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 1988; 95: 982988. (EL 3)
  • 656
    Rumessen JJ, Gudmand-Høyer E, Bachmann E, Justesen T. Diagnosis of bacterial overgrowth of the small intestine: comparison of the 14C-d-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol 1985; 20: 12671275. (EL 3)
  • 657
    Schneider A, Novis B, Chen V, Leichtman G. Value of the 14C-d-xylose breath test in patients with intestinal bacterial overgrowth. Digestion 1985; 32: 8691. (EL 3)
  • 658
    Attar A, Flourié B, Rambaud JC et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 1999; 117: 794797. (EL 3)
  • 659
    Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005; 21: 985992. (EL 3)
  • 660
    Correia MI, Nicoli JR. The role of probiotics in gastrointestinal surgery. Curr Opin Clin Nutr Metab Care 2006; 9: 618621. (EL 4)
  • 661
    Sugerman HJ, Kellum JM Jr., Reines HD et al. Greater risk of incisional hernia with morbidly obese than steroid-dependent patients and low recurrence with prefascial polypropylene mesh. Am J Surg 1996; 171: 8084. (EL 3)
  • 662
    Cucchi SG, Pories WJ, MacDonald KG, Morgan EJ. Gastrogastric fistulas: a complication of divided gastric bypass surgery. Ann Surg 1995; 221: 387391. (EL 3)
  • 663
    MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg 1993; 165: 155160. (EL 2)
  • 664
    Flancbaum L, Belsley S. Factors affecting morbidity and mortality of Roux-en-Y gastric bypass for clinically severe obesity: an analysis of 1,000 consecutive open cases by a single surgeon. J Gastrointest Surg 2007; 11: 500507. (EL 3)
  • 665
    Gumbs AA, Duffy AJ, Bell RL. Management of gastrogastric fistula after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 117121. (EL 3)
  • 666
    Carrodeguas L, Szomstein S, Soto F et al. Management of gastrogastric fistulas after divided Roux-en-Y gastric bypass surgery for morbid obesity: analysis of 1,292 consecutive patients and review of literature. Surg Obes Relat Dis 2005; 1: 467474. (EL 3)
  • 667
    Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet Gynecol 2000; 95: 927930. (EL 3)
  • 668
    American College of Obstetricians and Gynecologists. ACOG Committee opinion number 315, September 2005:obesity in pregnancy. Obstet Gynecol 2005; 106: 671675. (EL 4)
  • 669
    Gerrits EG, Ceulemans R, van Hee R, Hendrickx L, Totté E. Contraceptive treatment after biliopancreatic diversion needs consensus. Obes Surg 2003; 13: 378382. (EL 3)
  • 670
    Weiss HG, Nehoda H, Labeck B et al. Pregnancies after adjustable gastric banding. Obes Surg 2001; 11: 303306. (EL 3)
  • 671
    Bilenka B, Ben-Schlomo I, Cozacov C, Gold CH, Zohar S. Fertility, miscarriage and pregnancy after vertical banded gastroplasty operation for morbid obesity. Acta Obstet Gynecol Scand 1995; 74: 4244. (EL 3)
  • 672
    Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 2000; 74: 11961199. (EL 3)
  • 673
    Khong TY, Hague WM. The placenta in maternal hyperhomocysteinaemia. Br J Obstet Gynaecol 1999; 106: 273278. (EL 3)
  • 674
    Mathews TJ, Honein MA, Erickson JD. Spina bifida and anencephaly prevalence—United States, 1991–2001. MMWR Recomm Rep 2002; 51: 911. (EL 3)
  • 675
    Ramirez MM, Turrentine MA. Gastrointestinal hemorrhage during pregnancy in a patient with a history of vertical-banded gastroplasty. Am J Obstet Gynecol 1995; 173: 16301631. (EL 3)
  • 676
    Gurewitsch ED, Smith-Levitin M, Mack J. Pregnancy following gastric bypass surgery for morbid obesity. Obstet Gynecol 1996; 88: 658661. (EL 3)
  • 677
    Huerta S, Rogers LM, Li Z et al. Vitamin A deficiency in a newborn resulting from maternal hypovitaminosis A after biliopancreatic diversion for the treatment of morbid obesity. Am J Clin Nutr 2002; 76: 426429. (EL 3)
  • 678
    Woodard CB. Pregnancy following bariatric surgery. J Perinat Neonatal Nurs 2004; 18: 329340. (EL 4)
  • 679
    Haddow JE, Hill LE, Kloza EM, Thanhauser D. Neural tube defects after gastric bypass. Lancet 1986; 1: 1330. (EL 3)
  • 680
    Martin L, Chavez GF, Adams MJ Jr. et al. Gastric bypass surgery as maternal risk factor for neural tube defects. Lancet 1988; 1: 640641. (EL 3)
  • 681
    Marceau P, Kaufman D, Biron S et al. Outcome of pregnancies after biliopancreatic diversion. Obes Surg 2004; 14: 318324. (EL 3)
  • 682
    Bar-Zohar D, Azem F, Klausner J, Abu-Abeid S. Pregnancy after laparoscopic adjustable gastric banding: perinatal outcome is favorable also for women with relatively high gestational weight gain. Surg Endosc 2006; 20: 15801583. (EL 2)
  • 683
    Wu JK. Body contouring after bariatric surgery is critical for optimal cosmetic results. MedGenMed 2006; 8: 77. (EL 4)
  • 684
    American Society of Plastic Surgeons. Body Contouring After Massive Weight Loss <http:www.plasticsurgery.orgloader.cfmurlcommonspotsecuritygetfile.cfm&pageID16766> (2009). Accessed 23 April 2008. (EL 3)
  • 685
    Rohrich RJ. Body contouring after massive weight loss supplement. Plast Reconstr Surg 2006; 117 (Suppl 1):1S86S. (EL 4)
  • 686
    Shermak MA, Chang DC, Heller J. Factors impacting thromboembolism after bariatric body contouring surgery. Plast Reconstr Surg 2007; 119: 15901596. (EL 3)
  • 687
    Dymek MP, le Grange D, Neven K, Alverdy J. Quality of life and psychosocial adjustment in patients after Roux-en-Y gastric bypass: a brief report. Obes Surg 2001; 11: 3239. (EL 3)
  • 688
    van Gemert WG, Adang EM, Greve JW, Soeters PB. Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery. Am J Clin Nutr 1998; 67: 197201. (EL 3)
  • 689
    Choban PS, Onyejekwe J, Burge JC, Flancbaum L. A health status assessment of the impact of weight loss following Roux-en-Y gastric bypass for clinically severe obesity. J Am Coll Surg 1999; 188: 491497. (EL 3)
  • 690
    Schok M, Geenen R, van Antwerpen T et al. Quality of life after laparoscopic adjustable gastric banding for severe obesity: postoperative and retrospective preoperative evaluations. Obes Surg 2000; 10: 502508. (EL 3)
  • 691
    Wyss C, Laurent-Jacard A, Burckhardt P, Jayet A, Gazzola L. Long-term results on quality of life of surgical treatment of obesity with vertical banded gastroplasty. Obes Surg 1995; 5: 387392. (EL 3)
  • 692
    Solow C, Silberfarb PM, Swift K. Psychosocial effects of intestinal bypass surgery for severe obesity. N Engl J Med 1974; 290: 300304. (EL 3)
  • 693
    Adami GF, Meneghelli A, Bressani A, Scopinaro N. Body image in obese patients before and after stable weight reduction following bariatric surgery. J Psychosom Res 1999; 46: 275281. (EL 3)
  • 694
    Kinzl JF, Trefalt E, Fiala M et al. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001; 11: 455458. (EL 3)
  • 695
    Valley V, Grace DM. Psychosocial risk factors in gastric surgery for obesity: identifying guidelines for screening. Int J Obes 1987; 11: 105113. (EL 3)
  • 696
    Kuldau JM, Barnard G, Kreutziger S, Rand CS. Psychosocial effects of jejunoileal bypass for obesity: six-month follow-up. Psychosomatics 1979; 20: 462 467472. (EL 3)
  • 697
    Pories WJ, MacDonald KG. The surgical treatment of morbid obesity. In: Daly M (ed). Current Opinion in General Surgery. Current Science Ltd.: Philadelphia, PA, 1993, pp 195205. (EL 4)
  • 698
    Andersen T, Larsen U. Dietary outcome in obese patients treated with a gastroplasty program. Am J Clin Nutr 1989; 50: 13281340. (EL 3)
  • 699
    Näslund I, Järnmark I, Andersson H. Dietary intake before and after gastric bypass and gastroplasty for morbid obesity in women. Int J Obes 1988; 12: 503513. (EL 2)
  • 700
    Brolin RE. Bariatric surgery and long-term control of morbid obesity. JAMA 2002; 288: 27932796. (EL 4)
  • 701
    American Society for Parenteral and Enteral Nutrition. A.S.P.E.N. Guidelines and Standards Library <http:www.nutritioncare.orgLibrary.aspx> (2006). Accessed 23 April 2008. (EL 4)
  • 702
    Merritt R (In: The A.S.P.E.N. Nutrition Support Practice Manual, 2nd edn. American Society for Parenteral and Enteral Nutrition: Silver Spring, MD, 2005. (EL 4)
  • 703
    Segal A, Kinoshita Kussunoki D, Larino MA. Post-surgical refusal to eat: anorexia nervosa, bulimia nervosa or a new eating disorder? A case series. Obes Surg 2004; 14: 353360. (EL 3)
  • 704
    Schwartz RW, Strodel WE, Simpson WS, Griffen WO Jr. Gastric bypass revision: lessons learned from 920 cases. Surgery 1988; 104: 806812. (EL 3)
  • 705
    Schweitzer M. Endoscopic intraluminal suture plication of the gastric pouch and stoma in postoperative Roux-en-Y gastric bypass patients. J Laparoendosc Adv Surg Tech A 2004; 14: 223226. (EL 3)
  • 706
    Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol 1992; 87: 11651169. (EL 3)
  • 707
    Dresel A, Kuhn JA, McCarty TM. Laparoscopic Roux-en-Y gastric bypass in morbidly obese and super morbidly obese patients. Am J Surg 2004; 187: 230232. (EL 2)
  • 708
    Go MR, Muscarella P II, Needleman BJ, Cook CH, Melvin WS. Endoscopic management of stomal stenosis after Roux-en-Y gastric bypass. Surg Endosc 2004; 18: 5659. (EL 3)
  • 709
    Van Hee RH. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg 2004; 28: 435444. (EL 4)
  • 710
    Becker C. Stapling standards: group issues bariatric best-practice guidelines. Mod Healthc 2004; 34: 12. (EL 4)
  • 711
    Edwards MA, Grinbaum R, Ellsmere J, Jones DB, Schneider BE. Intussusception after Roux-en-Y gastric bypass for morbid obesity: case report and literature review of rare complication. Surg Obes Relat Dis 2006; 2: 483489. (EL 3)
  • 712
    Totté E, Hendrickx L, van Hee R et al. Biliopancreatic diversion for treatment of morbid obesity: experience in 180 consecutive cases. Obes Surg 1999; 9: 161165. (EL 3)
  • 713
    Gianetta E, Friedman D, Adami GF et al. Etiological factors of protein malnutrition after biliopancreatic diversion. Gastroenterol Clin North Am 1987; 16: 503504. (EL 4)
  • 714
    Behrns KE, Smith CD, Kelly KA, Sarr MG. Reoperative bariatric surgery: lessons learned to improve patient selection and results. Ann Surg 1993; 218: 646653. (EL 3)
  • 715
    Yale CE. Conversion surgery for morbid obesity: complications and long-term weight control. Surgery 1989; 106: 474480. (EL 3)
  • 716
    Pessa M, Robertson J, Woodward ER. Surgical management of the failed jejunoileal bypass. Am J Surg 1986; 151: 364367. (EL 4)
  • 717
    Kirkpatrick JR. Jejunoileal bypass: a legacy of late complications. Arch Surg 1987; 122: 610614. (EL 3)
  • 718
    Yale CE. Gastric bypass combined with reversal of intestinal bypass for morbid obesity. World J Surg 1980; 4: 723727. (EL 3)
  • 719
    Sugerman HJ, Wolper JL. Failed gastroplasty for morbid obesity: revised gastroplasty versus Roux-Y gastric bypass. Am J Surg 1984; 148: 331336. (EL 3)
  • 720
    Brolin RE, Ravitch MM. Experimental evaluation of techniques of gastric partitioning for morbid obesity. Surg Gynecol Obstet 1981; 153: 877882. (EL 3)
  • 721
    Buckwalter JA, Herbst CA Jr. Leaks occurring after gastric bariatric operations. Surgery 1988; 103: 156160. (EL 3)
  • 722
    Torres JC, Oca CF, Honer HM. Gastroplasty conversion to Roux-en-Y gastric bypass at the lesser curvature due to weight loss failure. Am Surg 1985; 51: 559562. (EL 3)
  • 723
    Roller JE, Provost DA. Revision of failed gastric restrictive operations to Roux-en-Y gastric bypass: impact of multiple prior bariatric operations on outcome. Obes Surg 2006; 16: 865869. (EL 3)
  • 724
    Hanni CL, Pool LR, Dean RE, Cronquist JC. Treatment of jejunoileal bypass failure by reanastomosis and gastroplasty in a single-stage procedure: review of 47 cases. Am Surg 1984; 50: 354357. (EL 3)
  • 725
    Robertson JW, Woodward ER. Gastric partition after reversal of jejunoileal bypass for morbid obesity: three-year follow-up. South Med J 1985; 78: 13141316. (EL 3)
  • 726
    Nesset EM, Kendrick ML, Houghton SG et al. A two-decade spectrum of revisional bariatric surgery at a tertiary referral center. Surg Obes Relat Dis 2007; 3: 2530. (EL 3)
  • 727
    Kim CH, Sarr MG. Severe reflux esophagitis after vertical banded gastroplasty for treatment of morbid obesity. Mayo Clin Proc 1992; 67: 3335. (EL 3)
  • 728
    de Csepel J, Nahouraii R, Gagner M. Laparoscopic gastric bypass as a reoperative bariatric surgery for failed open restrictive procedures. Surg Endosc 2001; 15: 393397. (EL 3)
  • 729
    Gagner M, Gentileschi P, de Csepel J et al. Laparoscopic reoperative bariatric surgery: experience from 27 consecutive patients. Obes Surg 2002; 12: 254260. (EL 3)
  • 730
    Kothari SN, DeMaria EJ, Sugerman HJ et al. Lap-Band failures: conversion to gastric bypass and their preliminary outcomes. Surgery 2002; 131: 625629. (EL 3)
  • 731
    de Csepel J, Quinn T, Pomp A, Gagner M. Conversion to a laparoscopic biliopancreatic diversion with a duodenal switch for failed laparoscopic adjustable silicone gastric banding. J Laparoendosc Adv Surg Tech A 2002; 12: 237240. (EL 3)
  • 732
    Fox SR. The use of the biliopancreatic diversion as a treatment for failed gastric partitioning in the morbidly obese. Obes Surg 1991; 1: 8993. (EL 3)
  • 733
    Sapala JA, Sapala MA, Resto Soto AD, Quarermus JF. A technique for converting the Roux-en Y gastric bypass to a modified biliopancreatic diversion. Obes Surg 1991; 1: 311313. (EL 3)
  • 734
    Van Dielen FM, Soeters PB, de Brauw LM, Greve JW. Laparoscopic adjustable gastric banding versus open vertical banded gastroplasty: a prospective randomized trial. Obes Surg 2005; 15: 12921298. (EL 2)
  • 735
    Nocca D, Aggarwal R, Blanc P et al. Laparoscopic vertical banded gastroplasty: a multicenter prospective study of 200 procedures. Surg Endosc 2007; 21: 870874. (EL 2)
  • 736
    van Mastrigt GA, van Dielen FM, Severens JL, Voss GB, Greve GW. One-year cost-effectiveness of surgical treatment of morbid obesity: vertical banded gastroplasty versus Lap-Band. Obes Surg 2006; 16: 7584. (EL 2)
  • 737
    Ren CJ, Horgan S, Ponce J. US experience with the LAP-BAND system. Am J Surg 2002; 184: 46S50S. (EL 4)
  • 738
    Belachew M, Belva PH, Desaive C. Long-term results of laparoscopic adjustable gastric banding for the treatment of morbid obesity. Obes Surg 2002; 12: 564568. (EL 3)
  • 739
    Melvin WS. Roux-en-Y gastric bypass is the operation of choice for bariatric surgery [with discussion]. J Gastrointest Surg 2004; 8: 398400, 404–405. (EL 4)
  • 740
    Biertho L, Steffen R, Branson R et al. Management of failed adjustable gastric banding. Surgery 2005; 137: 3341. (EL 3)
  • 741
    Ceelen W, Walder J, Cardon A et al. Surgical treatment of severe obesity with a low-pressure adjustable gastric band: experimental data and clinical results in 625 patients. Ann Surg 2003; 237: 1016. (EL 3)
  • 742
    Dargent J. Surgical treatment of morbid obesity by adjustable gastric band: the case for a conservative strategy in the case of failure—a 9-year series. Obes Surg 2004; 14: 986990. (EL 3)
  • 743
    Fox SR, Fox KM, Srikanth MS, Rumbaut R. The Lap-Band system in a North American population. Obes Surg 2003; 13: 275280. (EL 3)
  • 744
    Frigg A, Peterli R, Peters T, Ackermann C, Tondelli P. Reduction in co-morbidities 4 years after laparoscopic adjustable gastric banding. Obes Surg 2004; 14: 216223. (EL 3)
  • 745
    Greenslade J, Kow L, Toouli J. Surgical management of obesity using a soft adjustable gastric band. ANZ J Surg 2004; 74: 195199. (EL 2)
  • 746
    Holloway JA, Forney GA, Gould DE. The Lap-Band is an effective tool for weight loss even in the United States. Am J Surg 2004; 188: 659662. (EL 2)
  • 747
    Mittermair RP, Weiss H, Aigner F et al. Is it necessary to deflate the adjustable gastric band for subsequent operations? Am J Surg 2003; 185: 5053. (EL 2)
  • 748
    Ponce J, Haynes B, Paynter S et al. Effect of Lap-Band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg 2004; 14: 13351342. (EL 3)
  • 749
    Steffen R, Biertho L, Ricklin T, Piec G, Horber FF. Laparoscopic Swedish adjustable gastric banding: a five-year prospective study. Obes Surg 2003; 13: 404411. (EL 2)
  • 750
    Suter M, Giusti V, Worreth M, Héraief E, Calmes JM. Laparoscopic gastric banding: a prospective, randomized study comparing the Lap-Band and the SAGB; early results. Ann Surg 2005; 241: 5562. (EL 2)
  • 751
    Vertruyen M. Experience with Lap-Band System up to 7 years. Obes Surg 2002; 12: 569572. (EL 3)
  • 752
    Victorzon M, Tolonen P. Intermediate results following laparoscopic adjustable gastric banding for morbid obesity [with discussion]. Dig Surg 2002; 19: 354358. (EL 2)
  • 753
    Weiner R, Blanco-Engert R, Weiner S et al. Outcome after laparoscopic adjustable gastric banding—8 years experience. Obes Surg 2003; 13: 427434. (EL 2)
  • 754
    Zinzindohoue F, Chevallier JM, Douard R et al. Laparoscopic gastric banding: a minimally invasive surgical treatment for morbid obesity; prospective study of 500 consecutive patients. Ann Surg 2003; 237: 19. (EL 3)
  • 755
    Naef M, Naef U, Mouton WG, Wagner HE. Outcome and complications after laparoscopic Swedish adjustable gastric banding: 5-year results of a prospective clinical trial. Obes Surg 2007; 17: 195201. (EL 2)
  • 756
    Lee WJ, Wang W, Wei PL, Huang MT. Weight loss and improvement of obesity-related illness following laparoscopic adjustable gastric banding procedure for morbidly obese patients in Taiwan. J Formos Med Assoc 2006; 105: 887894. (EL 2)
  • 757
    Parikh MS, Fielding GA, Ren CJ. U.S. experience with 749 laparoscopic adjustable gastric bands: intermediate outcomes. Surg Endosc 2005; 19: 16311635. (EL 2)
  • 758
    Gleysteen JJ. Four-year weight loss Roux-Y-gastric bypass: anastomotic reinforcement not additive. Gastroenterol Clin North Am 1987; 16: 525527. (EL 3)
  • 759
    Higa KD, Ho T, Boone KB. Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A 2001; 11: 377382. (EL 2)
  • 760
    Jones KB Jr. Experience with the Roux-en-Y gastric bypass, and commentary on current trends. Obes Surg 2000; 10: 183185. (EL 3)
  • 761
    Linner JH. Comparative effectiveness of gastric bypass and gastroplasty: a clinical study. Arch Surg 1982; 117: 695700. (EL 3)
  • 762
    Oh C, Kim HJ, Oh S. Weight loss following transected gastric bypass with proximal Roux-en-Y. Obes Surg 1997; 7: 142147. (EL 3)
  • 763
    Rabkin RA. Distal gastric bypass/duodenal switch procedure, Roux-en-Y gastric bypass and biliopancreatic diversion in a community practice. Obes Surg 1998; 8: 5359. (EL 3)
  • 764
    Alami RS, Morton JM, Sanchez BR et al. Laparoscopic Roux-en-Y gastric bypass at a Veterans Affairs and high-volume academic facilities: a comparison of institutional outcomes. Am J Surg 2005; 190: 821825. (EL 3)
  • 765
    Inabnet WB, Quinn T, Gagner M, Urban M, Pomp A. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50:a prospective randomized trial comparing short and long limb lengths. Obes Surg 2005; 15: 5157. (EL 2)
  • 766
    Lee WJ, Yu PJ, Wang W et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005; 242: 2028. (EL 2)
  • 767
    Nelson LG, Lopez PP, Haines K et al. Outcomes of bariatric surgery in patients ≥65 years. Surg Obes Relat Dis 2006; 2: 384388. (EL 3)
  • 768
    Obeid F, Falvo A, Dabideen H et al. Open Roux-en-Y gastric bypass in 925 patients without mortality. Am J Surg 2005; 189: 352356. (EL 3)
  • 769
    Choban PS, Jackson B, Poplawski S, Bistolarides P. Bariatric surgery for morbid obesity: why, when, how, where, and then what? Cleve Clin J Med 2002; 69: 897903. (EL 4)
  • 770
    Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg 2005; 15: 408416. (EL 4)
  • 771
    Dolan K, Fielding G. Biliopancreatic diversion following failure of laparoscopic adjustable gastric banding. Surg Endosc 2004; 18: 6063. (EL 4)
  • 772
    Dolan K, Hatzifotis M, Newbury L, Lowe N, Fielding G. A clinical and nutritional comparison of biliopancreatic diversion with and without duodenal switch. Ann Surg 2004; 240: 5156. (EL 3)
  • 773
    Bajardi G, Ricevuto G, Mastrandrea G et al. Surgical treatment of morbid obesity with biliopancreatic diversion and gastric banding: report on an 8-year experience involving 235 cases. Ann Chir 2000; 125: 155162. (EL 3)
  • 774
    Anthone GJ, Lord RV, DeMeester TR, Crookes PF. The duodenal switch operation for the treatment of morbid obesity. Ann Surg 2003; 238: 618627. (EL 3)
  • 775
    Fujioka K. Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care 2005; 28: 481484. (EL 4)
  • 776
    Mason ME, Jalagani H, Vinik AI. Metabolic complications of bariatric surgery: diagnosis and management issues. Gastroenterol Clin North Am 2005; 34: 2533. (EL 4)
  • 777
    Alvarez-Leite JI. Nutrient deficiencies secondary to bariatric surgery. Curr Opin Clin Nutr Metab Care 2004; 7: 569575. (EL 4)